Processing 00000000.tx.1: Systematic Search for Single Nucleotide Polymorphisms in the Resistin Gene The Absence of Evidence for the Association of Three Identified Single Nucleotide Polymorphisms With Japanese Type 2 Diabetes Haruhiko Osawa1, Hiroshi Onuma1, Akiko Murakami1, Masaaki Ochi1, Tatsuya Nishimiya1, Kenichi Kato2, Ikki Shimizu2, Yasuhisa Fujii2, Jun Ohashi3, and Hideichi Makino1 1 Department of Laboratory Medicine, Ehime University School of Medicine, Ehime, Japan 2 Ehime Prefectural Hospital, Ehime, Japan 3 Department of Human Genetics, School of International Health, Graduate School of Medicine, University of Tokyo, Tokyo, Japan  ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS REFERENCES  Resistin is a novel polypeptide specifically secreted from adipocytes, and its serum levels are increased in obese diabetic mice. 

Phrase: "Systematic Search for Single Nucleotide Polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1552603:search [Intellectual Product]
   753   C1706202:Search [Activity]

Phrase: "in the Resistin Gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "The Absence of Evidence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "for the Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "of Three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "Identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "Single Nucleotide Polymorphisms With Japanese Type 2 Diabetes Haruhiko Osawa1,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   782   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   739   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0032529:polymorphisms [Genetic Function]
   739   C0037179:Single [Population Group]
   739   C0087136:single [Finding]
   739   C0205171:Single [Quantitative Concept]
   706 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "Hiroshi Onuma1,"

Phrase: "Akiko Murakami1,"

Phrase: "Masaaki Ochi1,"

Phrase: "Tatsuya Nishimiya1,"

Phrase: "Kenichi Kato2,"

Phrase: "Ikki Shimizu2,"

Phrase: "Yasuhisa Fujii2,"

Phrase: "Jun Ohashi3,"

Phrase: "and"

Phrase: "Hideichi Makino1 1 Department of Laboratory Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1704729:Department [Organization]

Phrase: "Ehime University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "Ehime,"

Phrase: "Japan 2 Ehime Prefectural Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   804   C1510665:Hospital [Qualitative Concept]
   721 E C1609061:Hospitals [Intellectual Product]

Phrase: "Ehime,"

Phrase: "Japan 3 Department of Human Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0587466:Genetics department [Health Care Related Organization]
   753   C1704729:Department [Organization]

Phrase: "School of International Health,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0036370:School Health [Health Care Activity]
   770   C0036375:School [Manufactured Object,Organization]

Phrase: "Graduate School of Medicine,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0870614:graduate school [Manufactured Object,Organization]
   770   C0036375:School [Manufactured Object,Organization]
   770   C0588053:Graduate [Population Group]
   770   C1547183:Graduate [Idea or Concept]

Phrase: "University of Tokyo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040371:Tokyo [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan  ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0035171:Research Design [Research Activity]
   795   C0035168:research [Research Activity]
   795   C0242481:Research [Research Activity]
   795   C1707689:Design [Activity]
   795   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Resistin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0963992:resistin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1426906:RESISTIN [Gene or Genome]

Phrase: "is"

Phrase: "a novel polypeptide specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "secreted from adipocytes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0206131:Adipocytes [Cell]
   790   C1327616:Secreted [Cell Function]

Phrase: "and"

Phrase: "its serum levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0229671:Serum [Body Substance]
   861   C0441889:Levels [Qualitative Concept]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "increased in obese diabetic mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0025933:Mice, Obese [Mammal]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0028754:Obese [Disease or Syndrome]
   760   C0205217:Increased [Quantitative Concept]
   760   C0241863:DIABETIC [Finding]
   760   C0442805:Increased [Functional Concept]
Processing 00000000.tx.2: Resistin antagonizes insulin and could account for insulin resistance. 

Phrase: "Resistin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0963992:resistin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1426906:RESISTIN [Gene or Genome]

Phrase: "antagonizes"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "could"

Phrase: "account for insulin resistance."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1551359:account [Idea or Concept]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.3: To determine whether there are single nucleotide polymorphisms (SNPs) in the resistin gene associated with type 2 diabetes, sequences for 24 Japanese type 2 diabetic patients were initially analyzed using PCR direct sequencing. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "there"

Phrase: "are"

Phrase: "single nucleotide polymorphisms (SNPs) in the resistin gene"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   814   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   774   C0678951:gene polymorphisms [Genetic Function]
   748   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0032529:polymorphisms [Genetic Function]
   748   C0037179:Single [Population Group]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "associated with type 2 diabetes,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "sequences for 24 Japanese type 2 diabetic patients"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0441730:Type 2 [Classification]
   750   C1550335:Patient type [Classification]
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0030705:Patients [Patient or Disabled Group]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C0241863:DIABETIC [Finding]
   744   C0332307:Type [Qualitative Concept]
   744   C1519249:Sequence [Functional Concept]
   744   C1547052:*Type [Quantitative Concept]
   744   C1556094:Japanese [Population Group]

Phrase: "were"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PCR direct sequencing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1553778:Sequencing [Intellectual Product]
   827   C1561491:Sequencing [Functional Concept]
Processing 00000000.tx.4: Three SNPs were found in the introns, but none were present in the coding regions. 

Phrase: "Three SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "found in the introns,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0021920:Introns [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "but"

Phrase: "none"

Phrase: "were"

Phrase: "present in the coding regions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
Processing 00000000.tx.5: The allele frequencies of genomic -167C>T, +157C>T, and +299G>A in 99 Japanese control subjects were determined to be 3.5, 6.6, and 39.4%, respectively. 

Phrase: "The allele frequencies of genomic -167C"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0017270:Frequencies, Allele [Quantitative Concept]
   753   C0439603:Frequencies [Temporal Concept]
   719 E C0376249:frequency [Quantitative Concept]
   719 E C0871396:Frequency [Quantitative Concept]
   719 E C1561548:Frequency [Qualitative Concept]
   719 E C1705502:Frequency [Quantitative Concept]

Phrase: ">T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "+157C"

Phrase: ">T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and +"

Phrase: "299G"

Phrase: ">A in 99 Japanese control subjects"

Phrase: "were"

Phrase: "determined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "3.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442758:3 5 [Quantitative Concept]
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "6.6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442750:6/6 [Finding]

Phrase: "and"

Phrase: "39.4%,"

Phrase: "respectively."
Processing 00000000.tx.6: In each pair of these SNPs, linkage disequilibria were found between either -167C>T and +299G>A or +157C>T and +299G>A. 

Phrase: "In each pair"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709450:Pair [Qualitative Concept]

Phrase: "of these SNPs,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "linkage disequilibria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0023746:Linkage Disequilibrium [Quantitative Concept]
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "were"

Phrase: "found between either -167C"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: ">T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and +"

Phrase: "299G"

Phrase: ">"

Phrase: "A or +157C"

Phrase: ">T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and +"

Phrase: "299G"

Phrase: ">A."
Processing 00000000.tx.7: A linkage disequilibrium was also detected among -167C>T, +157C>T, and +299G>A, and only four of the eight possible haplotypes defined by these SNPs were found. 

Phrase: "A linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "was"

Phrase: "also"

Phrase: "detected among -167C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ">T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "+157C"

Phrase: ">T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and +"

Phrase: "299G"

Phrase: ">A,"

Phrase: "and"

Phrase: "only four of the eight possible haplotypes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0018591:Haplotypes [Organism Attribute]
   748   C0205171:Only [Quantitative Concept]
   748   C0205450:Four [Quantitative Concept]
   748   C0205454:Eight [Quantitative Concept]
   748   C0332149:Possible [Qualitative Concept]
   748   C1705910:Possible [Qualitative Concept]
   748   C1720467:Only [Intellectual Product]
   748   C2362652:Possible [Qualitative Concept]

Phrase: "defined by these SNPs"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   753   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0032529:polymorphisms [Genetic Function]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C1704788:Defined [Conceptual Entity]
   753   C3539106:Defined [Intellectual Product]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "found."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]
Processing 00000000.tx.8: A comparison of the frequencies of these SNPs and haplotypes between 99 type 2 diabetes and 99 control subjects revealed no evidence for any association. 

Phrase: "A comparison of the frequencies of these SNPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "haplotypes between 99 type 2 diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0018591:Haplotypes [Organism Attribute]

Phrase: "and"

Phrase: "99 control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "no evidence for any association."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.9: These identified SNPs, which were in linkage disequilibrium, represent potentially useful tools for searching for their association with specific phenotypes of diabetes.  

Phrase: "These identified SNPs,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "which"

Phrase: "were in linkage disequilibrium,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "potentially useful tools for searching"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C2348167:Search Tool [Intellectual Product]
   762   C0871532:tools use [Finding]
   726   C0336791:Tool [Manufactured Object]
   726   C2827396:Tool [Manufactured Object]

Phrase: "for their association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with specific phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031437:Phenotypes [Organism Attribute]
   827 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "of diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.10: INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS REFERENCES  Type 2 diabetes is characterized by insulin resistance in insulin target tissues and an impaired insulin secretion from pancreatic -cells (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "characterized by insulin resistance"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1880022:Characterized [Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in insulin target tissues"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0040300:Tissues [Tissue]
   827   C1521840:Target [Functional Concept]
   827   C2986546:TARGET [Diagnostic Procedure]
   793 E C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "an impaired insulin secretion from pancreatic -cells"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C1256369:insulin secretion [Cell Function]
   774   C0030296:Pancreatic Secretion [Body Substance]
   774   C0232787:Pancreatic secretion [Organ or Tissue Function]
   757   C0030281:Insulin Cell [Cell]
   757   C1327616:Cell secretion [Cell Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.11: Gene mutations, which are associated with this disease, have been identified in molecules such as insulin and insulin receptor (2). 

Phrase: "Gene mutations,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0596611:gene mutations [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "which"

Phrase: "are"

Phrase: "associated with this disease,"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "identified in molecules"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0205396:Identified [Qualitative Concept]
   790   C0567416:molecules [Substance]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   706 E C1521991:Molecular [Qualitative Concept]

Phrase: "such as insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.12: These mutations account for specific types of diabetes as single genetic factors and constitute only a small proportion of all type 2 diabetic cases. 

Phrase: "These mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "account for specific types of diabetes"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   783   C1320657:diabetes types [Finding]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0205369:Specific [Qualitative Concept]
   753   C0332307:Types [Qualitative Concept]
   753   C1551359:account [Idea or Concept]
   753   C1552740:specific [Intellectual Product]
   753   C2741673:Account # [Clinical Attribute]
   753   C2981730:Account [Classification]
   719 E C1547052:*Type [Quantitative Concept]

Phrase: "as single genetic factors"
Meta Candidates (Total=19; Excluded=14; Pruned=0; Remaining=5)
   873   C2235729:Single birth NOS [Finding]
   827   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   827   C0314603:Genetic [Functional Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
   771 E C0005615:Birth [Organism Function]
   771 E C0035150:Reproduction [Organism Function]
   771 E C0079946:origin [Classification]
   771 E C0439659:Origin [Temporal Concept]
   771 E C1550512:origin [Intellectual Product]
   771 E C1550722:birth [Idea or Concept]
   771 E C3245487:birth [Intellectual Product]
   743 E C0454729:Natal [Geographic Area]
   743 E C0559522:Genital [Body System]
   743 E C1546649:Genital [Intellectual Product]
   743 E C1550642:Genital [Body Substance]
   734 E C0205313:Original [Idea or Concept]
   734 E C2347409:Original [Occupational Activity]
   716 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "constitute"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a small proportion of all type 2 diabetic cases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1709707:Proportion [Quantitative Concept]
Processing 00000000.tx.13: Common type 2 diabetes is thought to be a polygenic disease, and its major genetic factors remain to be elucidated. 

Phrase: "Common type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0011860:Type 2 Diabetes [Disease or Syndrome]
   875   C1320657:type diabetes [Finding]
   861   C0441730:Type 2 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a polygenic disease,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "its major genetic factors"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
   827   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   827   C0314603:Genetic [Functional Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
   771 E C0005615:Birth [Organism Function]
   771 E C0035150:Reproduction [Organism Function]
   771 E C0079946:origin [Classification]
   771 E C0439659:Origin [Temporal Concept]
   771 E C1550512:origin [Intellectual Product]
   771 E C1550722:birth [Idea or Concept]
   771 E C3245487:birth [Intellectual Product]
   743 E C0454729:Natal [Geographic Area]
   743 E C0559522:Genital [Body System]
   743 E C1546649:Genital [Intellectual Product]
   743 E C1550642:Genital [Body Substance]
   734 E C0205313:Original [Idea or Concept]
   734 E C2347409:Original [Occupational Activity]
   716 E C0598240:originality [Mental Process]

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elucidated."
Processing 00000000.tx.14: Most recently, it has been reported that single nucleotide polymorphisms (SNPs) in calpain-10 and peroxisome proliferatoractivated receptor- (PPAR-) are associated with type 2 diabetes (3,4). 

Phrase: "Most recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205393:Most [Quantitative Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that single nucleotide polymorphisms"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: ")"

Phrase: "in calpain-10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0961737:calpain 10 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413110:CALPAIN 10 [Gene or Genome]
   861   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "peroxisome proliferatoractivated receptor-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "associated with type 2 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.15: Resistin (resistance to insulin) was recently discovered as a polypeptide that is specifically secreted from adipocytes (5). 

Phrase: "Resistin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0963992:resistin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1426906:RESISTIN [Gene or Genome]

Phrase: "(resistance to insulin"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   858   C0021655:Insulin Resistance [Pathologic Function]
   858   C2700570:INSULIN RESISTANCE [Gene or Genome]
   847   C0332325:Resistant to [Functional Concept]
       E   Resistant
   790   C0237834:Resistance [Mental Process]
   790   C1514892:Resistance [Physiologic Function]
   718 E C1550464:resistent [Idea or Concept]
   718 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: ")"

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "discovered as a polypeptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]
   737   C1880355:Discover [Activity]

Phrase: "that"

Phrase: "is"

Phrase: "specifically"

Phrase: "secreted from adipocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0206131:Adipocytes [Cell]
   790   C1327616:Secreted [Cell Function]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.16: Serum levels of resistin are increased in both genetic (ob/ob and db/db) and diet-induced obese diabetic mice. 

Phrase: "Serum levels of resistin"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0229671:Serum [Body Substance]
   770   C0441889:Levels [Qualitative Concept]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "increased in both genetic"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0205217:Increased [Quantitative Concept]
   770   C0314603:Genetic [Functional Concept]
   770   C0442805:Increased [Functional Concept]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: "(ob/ob"

Phrase: "and"

Phrase: "db/db)"

Phrase: "and"

Phrase: "diet-induced obese diabetic mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0025933:Mice, Obese [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
Processing 00000000.tx.17: Treatment with the PPAR- ligand rosiglitazone reduces serum resistin levels in mice. 

Phrase: "Treatment with the PPAR-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "ligand rosiglitazone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0289313:rosiglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "reduces"

Phrase: "serum resistin levels in mice."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.18: Interestingly, rosiglitazone also reduces resistin gene expression in 3T3-L1 adipocytes. 

Phrase: "Interestingly,"

Phrase: "rosiglitazone also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0289313:rosiglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "reduces"

Phrase: "resistin gene expression in 3T3-L1 adipocytes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0017262:Gene Expression [Genetic Function]
   748   C0017337:Gene [Gene or Genome]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.19: Resistin antagonizes the effect of insulin both in vitro and in vivo (5). 

Phrase: "Resistin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0963992:resistin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1426906:RESISTIN [Gene or Genome]

Phrase: "antagonizes"

Phrase: "the effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "both in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.20: An anti-resistin antibody improves blood glucose levels and insulin sensitivity in diet-induced obese mice, whereas recombinant resistin impairs glucose tolerance and the action of insulin in normal mice. 

Phrase: "An anti-resistin antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "improves"

Phrase: "blood glucose levels"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
  1000   C0428554:blood glucose levels [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "insulin sensitivity in diet-induced obese mice,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0920563:Insulin Sensitivity [Pathologic Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]

Phrase: "whereas"

Phrase: "recombinant resistin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0963992:resistin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1426906:RESISTIN [Gene or Genome]

Phrase: "impairs"

Phrase: "glucose tolerance"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0178665:Glucose tolerance [Physiologic Function]
   861   C0013220:Tolerance [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0020963:Tolerance [Pathologic Function]
   861   C0220929:tolerance [Mental Process]
   861   C0231197:Tolerance [Physiologic Function]
   861   C1704410:Tolerance [Qualitative Concept]
   805 E C0680282:toleration [Social Behavior]
   789 E C0231198:Tolerant [Functional Concept]

Phrase: "and"

Phrase: "the action of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441472:Action [Functional Concept]
   770   C3266814:Action [Activity]

Phrase: "in normal mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.21: In 3T3-L1 adipocytes, insulin-stimulated glucose uptake is enhanced by the immunoneutralization of resistin and is also blunted by recombinant resistin. 

Phrase: "In 3T3-L1 adipocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206131:Adipocytes [Cell]

Phrase: "insulin-stimulated glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1159527:glucose uptake [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "is"

Phrase: "enhanced by the immunoneutralization of resistin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0963992:resistin [Amino Acid, Peptide, or Protein,Hormone]
   753   C1426906:RESISTIN [Gene or Genome]
   753   C2349975:Enhanced [Activity]

Phrase: "and"

Phrase: "is"

Phrase: "also"

Phrase: "blunted by recombinant resistin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0963992:resistin [Amino Acid, Peptide, or Protein,Hormone]
   770   C1426906:RESISTIN [Gene or Genome]
   770   C1514798:recombinant [Organism]
   770   C1997138:Blunted [Qualitative Concept]
Processing 00000000.tx.22: Therefore, resistin represents a potential candidate gene for the insulin resistance observed in type 2 diabetes. 

Phrase: "Therefore,"

Phrase: "resistin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0963992:resistin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1426906:RESISTIN [Gene or Genome]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a potential candidate gene for the insulin resistance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1332838:Candidate Gene [Gene or Genome]
   767   C0079429:A Gene [Gene or Genome]
   767   C1337112:Insulin Gene [Gene or Genome]
   767   C2945710:resistance gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]

Phrase: "observed in type 2 diabetes."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.23: In view of this, we initiated a systematic search for SNPs in the resistin gene of Japanese subjects. 

Phrase: "In view of this,"

Phrase: "we"

Phrase: "initiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548602:Initiate [Idea or Concept]
   966   C1704686:Initiate [Functional Concept]

Phrase: "a systematic search for SNPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1552603:search [Intellectual Product]
   748   C1706202:Search [Activity]

Phrase: "in the resistin gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "of Japanese subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.24: The exon-intron boundaries were determined based on the human draft sequence for the FiZZ 3 (found in inflammatory zone 3) gene on chromosome 19 (GenBank accession no. NT_011145) and the human resistin cDNA sequence (no. AF323081). 

Phrase: "The exon-intron boundaries"

Phrase: "were"

Phrase: "determined"

Phrase: "based on the human draft sequence"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   767   C0004793:Base Sequence [Nucleotide Sequence]
           Sequence
   753   C0086418:Human [Human]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]
   753   C1527178:Based [Functional Concept]
   753   C1547277:Draft [Intellectual Product]
   753   C1705938:Based [Idea or Concept]
   753   C3245506:Draft [Intellectual Product]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "for the FiZZ 3"

Phrase: "("

Phrase: "found in inflammatory zone 3"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1426906:FOUND IN INFLAMMATORY ZONE 3 [Gene or Genome]
   806   C1517913:Zone 3 [Body Location or Region]
   760   C0150312:Found [Quantitative Concept]
   760   C0333348:Inflammatory [Functional Concept]
   760   C1710706:Zone [Spatial Concept]
   726 E C0243095:Find [Finding]

Phrase: ")"

Phrase: "gene on chromosome 19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017337:Gene [Gene or Genome]

Phrase: "(GenBank accession"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1510755:Accession [Intellectual Product]
   861   C1706078:Accession [Activity]

Phrase: "no. NT_011145"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332126:NT [Qualitative Concept]
   861   C1449832:NT [Diagnostic Procedure]

Phrase: ")"

Phrase: "and"

Phrase: "the human resistin cDNA sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C1519249:Sequence [Functional Concept]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]

Phrase: "("

Phrase: "no. AF323081"

Phrase: ")."
Processing 00000000.tx.25: We initially examined the three exons, as well as the introns of the resistin gene, in 24 type 2 diabetic patients using PCR direct sequencing (Table 1 lists the primers used). 

Phrase: "We initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the three exons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as well as"

Phrase: "the introns of the resistin gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0021920:Introns [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in 24 type 2 diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030705:Patients [Patient or Disabled Group]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PCR direct sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1553778:Sequencing [Intellectual Product]
   827   C1561491:Sequencing [Functional Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "lists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0745732:List [Conceptual Entity]
  1000   C3272378:LIST [Intellectual Product]

Phrase: "the primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.26: The sequencing of both strands revealed the presence of three intronic SNPs, namely, genomic (g.) 

Phrase: "The sequencing of both strands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1553778:Sequencing [Intellectual Product]
   760   C1561491:Sequencing [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the presence of three intronic SNPs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "namely,"

Phrase: "genomic (g.)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017428:Genomic [Gene or Genome]
  1000   C0887950:genomic [Biomedical Occupation or Discipline]
Processing 00000000.tx.27: -167C>T, +157C>T, and +299G>A. 

Phrase: "-167C"

Phrase: ">T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "+157C"

Phrase: ">T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and +"

Phrase: "299G"

Phrase: ">A."
Processing 00000000.tx.28: These SNPs did not involve splice/donor sites. 

Phrase: "These SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involve"

Phrase: "splice/donor sites."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0887917:Donor Sites, Splice [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C1444716:donor sites [Body Location or Region]
   827   C0013018:Donor [Population Group]
   827   C0040288:Donor [Population Group]
   827   C0205145:Sites [Spatial Concept]
   827   C1527169:Donor NOS [Finding]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.29: View this table: [in this window] [in a new window]  TABLE 1 Primers used for PCR and sequencing of the resistin gene  We then further sequenced the regions with these three SNPs in 99 control subjects (Table 2 lists clinical data). 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1 Primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "used for PCR"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "sequencing of the resistin gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1294197:Gene Sequencing [Laboratory Procedure]
   760   C1553778:Sequencing [Intellectual Product]
   760   C1561491:Sequencing [Functional Concept]

Phrase: "We then further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883708:Then [Temporal Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "the regions with these three SNPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0017446:Region [Geographic Area]
   711   C0205147:Region [Spatial Concept]

Phrase: "in 99 control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "lists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0745732:List [Conceptual Entity]
  1000   C3272378:LIST [Intellectual Product]

Phrase: "clinical data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1516606:Clinical Data [Intellectual Product]
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.30: The allele frequencies of g. 

Phrase: "The allele frequencies of g."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   806   C0017270:Frequencies, Allele [Quantitative Concept]
   760   C0439603:Frequencies [Temporal Concept]
   726 E C0376249:frequency [Quantitative Concept]
   726 E C0871396:Frequency [Quantitative Concept]
   726 E C1561548:Frequency [Qualitative Concept]
   726 E C1705502:Frequency [Quantitative Concept]
Processing 00000000.tx.31: -167C>T, +157C>T, +299G>A were 3.5, 6.6, and 39.4%, respectively (Table 3). 

Phrase: "-167C"

Phrase: ">T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "+157C"

Phrase: ">T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "+299G"

Phrase: ">A"

Phrase: "were"

Phrase: "3.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442758:3 5 [Quantitative Concept]
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "6.6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442750:6/6 [Finding]

Phrase: "and"

Phrase: "39.4%,"

Phrase: "respectively"

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.32: We then examined the linkage disequilibrium between any two pairs of these three SNPs. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the linkage disequilibrium between any two pairs of these three SNPs."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   750   C0023746:Linkage Disequilibrium [Quantitative Concept]
   749   C1883037:Single Linkage [Research Activity]
   735   C0023745:linkage [Molecular Function]
   735   C0281825:Disequilibrium [Finding]
   735   C0394006:Disequilibrium [Disease or Syndrome]
Processing 00000000.tx.33: Linkage disequilibrium was found between two of the three pairs. 

Phrase: "Linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "was"

Phrase: "found between two of the three pairs."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0150312:Found [Quantitative Concept]
   748   C0205448:Two [Quantitative Concept]
   748   C0205449:Three [Quantitative Concept]
   748   C1709450:Pair [Qualitative Concept]
   714 E C0243095:Find [Finding]
Processing 00000000.tx.34: The first was detected between -167C>T and +299G>A (Table 4A). 

Phrase: "The first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "was"

Phrase: "detected between -167C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ">T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and +"

Phrase: "299G"

Phrase: ">A (Table 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450373:4a [Intellectual Product]
   827   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.35: The estimated haplotype frequencies were f (CG) = 0.60, f (CA) = 0.36, f (TG) = 0.00, and f (TA) = 0.04. 

Phrase: "The estimated haplotype frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0439603:Frequencies [Temporal Concept]
   793 E C0376249:frequency [Quantitative Concept]
   793 E C0871396:Frequency [Quantitative Concept]
   793 E C1561548:Frequency [Qualitative Concept]
   793 E C1705502:Frequency [Quantitative Concept]
   743 E C0332183:Frequent [Temporal Concept]

Phrase: "were"

Phrase: "f (CG) = 0.60,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]
   812   C3540479:CG [Gene or Genome]

Phrase: "f (CA) = 0.36,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "f (TG) = 0.00,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0337445:TG [Laboratory Procedure]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "f (TA) = 0.04."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1506978:Ta [Immunologic Factor]
   812   C1553038:[f] [Quantitative Concept]
   812   C1705538:TA [Idea or Concept]
Processing 00000000.tx.36: The other was found between +157C>T and +299G>A. 

Phrase: "The"

Phrase: "other"

Phrase: "was"

Phrase: "found between +157C"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: ">T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and +"

Phrase: "299G"

Phrase: ">A."
Processing 00000000.tx.37: The estimated haplotype frequencies were f (CG) = 0.61, f (CA) = 0.33, f (TG) = 0.00, and f (TA) = 0.06. 

Phrase: "The estimated haplotype frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0439603:Frequencies [Temporal Concept]
   793 E C0376249:frequency [Quantitative Concept]
   793 E C0871396:Frequency [Quantitative Concept]
   793 E C1561548:Frequency [Qualitative Concept]
   793 E C1705502:Frequency [Quantitative Concept]
   743 E C0332183:Frequent [Temporal Concept]

Phrase: "were"

Phrase: "f (CG) = 0.61,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]
   812   C3540479:CG [Gene or Genome]

Phrase: "f (CA) = 0.33,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "f (TG) = 0.00,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0337445:TG [Laboratory Procedure]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "f (TA) = 0.06."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1506978:Ta [Immunologic Factor]
   812   C1553038:[f] [Quantitative Concept]
   812   C1705538:TA [Idea or Concept]
Processing 00000000.tx.38: The linkage disequilibrium was also found among these three SNPs, and only four of the eight possible haplotypes defined by these SNPs were detected (Table 4B). 

Phrase: "The linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "was"

Phrase: "also"

Phrase: "found among these three SNPs,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   814   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   748   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0032529:polymorphisms [Genetic Function]
   748   C0037179:Single [Population Group]
   748   C0087136:single [Finding]
   748   C0150312:Found [Quantitative Concept]
   748   C0205171:Single [Quantitative Concept]
   748   C0205449:Three [Quantitative Concept]
   714 E C0243095:Find [Finding]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "only four of the eight possible haplotypes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0018591:Haplotypes [Organism Attribute]
   748   C0205171:Only [Quantitative Concept]
   748   C0205450:Four [Quantitative Concept]
   748   C0205454:Eight [Quantitative Concept]
   748   C0332149:Possible [Qualitative Concept]
   748   C1705910:Possible [Qualitative Concept]
   748   C1720467:Only [Intellectual Product]
   748   C2362652:Possible [Qualitative Concept]

Phrase: "defined by these SNPs"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   753   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0032529:polymorphisms [Genetic Function]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C1704788:Defined [Conceptual Entity]
   753   C3539106:Defined [Intellectual Product]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Table 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.39: The estimated haplotype frequencies were f (CCG) = 0.60, f (CCA) = 0.29, f (CTA) = 0.07, and f (TCA) = 0.04. 

Phrase: "The estimated haplotype frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0439603:Frequencies [Temporal Concept]
   793 E C0376249:frequency [Quantitative Concept]
   793 E C0871396:Frequency [Quantitative Concept]
   793 E C1561548:Frequency [Qualitative Concept]
   793 E C1705502:Frequency [Quantitative Concept]
   743 E C0332183:Frequent [Temporal Concept]

Phrase: "were"

Phrase: "f (CCG) = 0.60,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1516476:CCG [Health Care Related Organization]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "f (CCA) = 0.29,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0220668:CCA [Congenital Abnormality]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "f (CTA) = 0.07,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]
   812   C3540513:CTA [Gene or Genome]

Phrase: "and"

Phrase: "f (TCA) = 0.04."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0041405:TCA [Geographic Area]
   812   C0085758:TCA [Congenital Abnormality]
   812   C0439133:(f) [Intellectual Product]
   812   C1415587:TCA [Gene or Genome]
   812   C1553038:[f] [Quantitative Concept]
   812   C3536819:TCA [Pharmacologic Substance]
Processing 00000000.tx.40: View this table: [in this window] [in a new window]  TABLE 2 Clinical features of the control and type 2 diabetic subjects  View this table: [in this window] [in a new window]  TABLE 3 Allele frequency of SNPs in the resistin gene for control and type 2 diabetic subjects  View this table: [in this window] [in a new window]  TABLE 4 Linkage disequilibrium between the identified SNPs in the resistin gene in Japanese subjects  We next sequenced the regions with these three SNPs in 75 additional type 2 diabetic patients, and we compared the allele frequencies of these SNPs between 99 type 2 diabetic patients and 99 nondiabetic control subjects (Table 2 lists clinical data). 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 2 Clinical features of the control"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   714   C1521970:Feature [Qualitative Concept]
   714   C1706388:Feature [Conceptual Entity]
   714   C2346469:Feature [Qualitative Concept]
   714   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "type 2 diabetic subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 3 Allele frequency of SNPs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0017270:Allele Frequency [Quantitative Concept]
   744   C0376249:frequency [Quantitative Concept]
   744   C0439603:Frequency [Temporal Concept]
   744   C0871396:Frequency [Quantitative Concept]
   744   C1561548:Frequency [Qualitative Concept]
   744   C1705502:Frequency [Quantitative Concept]

Phrase: "in the resistin gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "for control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "type 2 diabetic subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 4 Linkage disequilibrium between the identified SNPs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0023746:Linkage Disequilibrium [Quantitative Concept]
   757   C1883037:Single Linkage [Research Activity]
   739   C0023745:linkage [Molecular Function]
   739   C0281825:Disequilibrium [Finding]
   739   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "in the resistin gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "in Japanese subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "the regions with these three SNPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0017446:Region [Geographic Area]
   711   C0205147:Region [Spatial Concept]

Phrase: "in 75 additional type 2 diabetic patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the allele frequencies of these SNPs"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0017270:Frequencies, Allele [Quantitative Concept]
   744   C0439603:Frequencies [Temporal Concept]
   711 E C0376249:frequency [Quantitative Concept]
   711 E C0871396:Frequency [Quantitative Concept]
   711 E C1561548:Frequency [Qualitative Concept]
   711 E C1705502:Frequency [Quantitative Concept]

Phrase: "between 99 type 2 diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "99 nondiabetic control subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "lists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0745732:List [Conceptual Entity]
  1000   C3272378:LIST [Intellectual Product]

Phrase: "clinical data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1516606:Clinical Data [Intellectual Product]
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.41: No significant differences in the allele frequencies of either g. 

Phrase: "No significant differences in the allele frequencies of either g."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   706   C1705241:*Difference [Quantitative Concept]
   706   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.42: -167C>T, +157C>T, or +299G>A were detected between type 2 diabetes and the control subjects (Table 3). 

Phrase: "-167C"

Phrase: ">T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "+157C"

Phrase: ">T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "or +299G"

Phrase: ">A"

Phrase: "were"

Phrase: "detected between type 2 diabetes"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "the control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.43: The estimated haplotype frequencies were then determined for type 2 diabetes. 

Phrase: "The estimated haplotype frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0439603:Frequencies [Temporal Concept]
   793 E C0376249:frequency [Quantitative Concept]
   793 E C0871396:Frequency [Quantitative Concept]
   793 E C1561548:Frequency [Qualitative Concept]
   793 E C1705502:Frequency [Quantitative Concept]
   743 E C0332183:Frequent [Temporal Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "determined for type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.44: In these 99 type 2 diabetic subjects, the same linkage disequilibria as for the normal control subjects were found, and the estimated haplotype frequencies were also similar to those in normal control subjects. 

Phrase: "In these 99 type 2 diabetic subjects,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   771   C0681850:Subject [Group]
   771   C1550501:{Subject} [Idea or Concept]
   771   C1706203:Subject [Idea or Concept]
   771   C2349001:Subject [Human]
   771   C2697811:Subject [Functional Concept]

Phrase: "the same linkage disequilibria as for the normal control subjects"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   743   C0023746:Linkage Disequilibrium [Quantitative Concept]
   706   C0281825:Disequilibrium [Finding]
   706   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: ","

Phrase: "and"

Phrase: "the estimated haplotype frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0439603:Frequencies [Temporal Concept]
   793 E C0376249:frequency [Quantitative Concept]
   793 E C0871396:Frequency [Quantitative Concept]
   793 E C1561548:Frequency [Qualitative Concept]
   793 E C1705502:Frequency [Quantitative Concept]
   743 E C0332183:Frequent [Temporal Concept]

Phrase: "were"

Phrase: "also similar to those in normal control subjects."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.45: The estimated haplotype frequencies between -167C>T and +299G>A were f (CG) = 0.64, f (CA) = 0.34, f (TG) = 0.00, and f (TA) = 0.02. 

Phrase: "The estimated haplotype frequencies between -167C"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   753   C0439603:Frequencies [Temporal Concept]
   719 E C0376249:frequency [Quantitative Concept]
   719 E C0871396:Frequency [Quantitative Concept]
   719 E C1561548:Frequency [Qualitative Concept]
   719 E C1705502:Frequency [Quantitative Concept]

Phrase: ">T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and +"

Phrase: "299G"

Phrase: ">A"

Phrase: "were"

Phrase: "f (CG) = 0.64,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C0615276:F-64 [Organic Chemical,Pharmacologic Substance]
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]
   812   C3540479:CG [Gene or Genome]

Phrase: "f (CA) = 0.34,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "f (TG) = 0.00,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0337445:TG [Laboratory Procedure]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "f (TA) = 0.02."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1506978:Ta [Immunologic Factor]
   812   C1553038:[f] [Quantitative Concept]
   812   C1705538:TA [Idea or Concept]
Processing 00000000.tx.46: The estimated haplotype frequencies between +157C>T and + 299G>A were f (CG) = 0.64, f (CA) = 0.30, f (TG) = 0.00, and f (TA) = 0.06. 

Phrase: "The estimated haplotype frequencies between +157C"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   753   C0439603:Frequencies [Temporal Concept]
   719 E C0376249:frequency [Quantitative Concept]
   719 E C0871396:Frequency [Quantitative Concept]
   719 E C1561548:Frequency [Qualitative Concept]
   719 E C1705502:Frequency [Quantitative Concept]

Phrase: ">T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and +"

Phrase: "299G"

Phrase: ">A"

Phrase: "were"

Phrase: "f (CG) = 0.64,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C0615276:F-64 [Organic Chemical,Pharmacologic Substance]
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]
   812   C3540479:CG [Gene or Genome]

Phrase: "f (CA) = 0.30,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "f (TG) = 0.00,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0337445:TG [Laboratory Procedure]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "f (TA) = 0.06."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1506978:Ta [Immunologic Factor]
   812   C1553038:[f] [Quantitative Concept]
   812   C1705538:TA [Idea or Concept]
Processing 00000000.tx.47: The estimated haplotype frequencies between these three SNPs were f (CCG) = 0.64, f (CCA) = 0.28, f (CTA) = 0.06, and f (TCA) = 0.02. 

Phrase: "The estimated haplotype frequencies between these three SNPs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   739   C0439603:Frequencies [Temporal Concept]
   706 E C0376249:frequency [Quantitative Concept]
   706 E C0871396:Frequency [Quantitative Concept]
   706 E C1561548:Frequency [Qualitative Concept]
   706 E C1705502:Frequency [Quantitative Concept]

Phrase: "were"

Phrase: "f (CCG) = 0.64,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0615276:F-64 [Organic Chemical,Pharmacologic Substance]
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1516476:CCG [Health Care Related Organization]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "f (CCA) = 0.28,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0220668:CCA [Congenital Abnormality]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "f (CTA) = 0.06,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]
   812   C3540513:CTA [Gene or Genome]

Phrase: "and"

Phrase: "f (TCA) = 0.02."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0041405:TCA [Geographic Area]
   812   C0085758:TCA [Congenital Abnormality]
   812   C0439133:(f) [Intellectual Product]
   812   C1415587:TCA [Gene or Genome]
   812   C1553038:[f] [Quantitative Concept]
   812   C3536819:TCA [Pharmacologic Substance]
Processing 00000000.tx.48: To examine whether other SNPs exist, the entire resistin gene was also sequenced in 25 of the 75 type 2 diabetic patients, in addition to the initial screening, which involved 24 patients. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "other SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: ","

Phrase: "the entire resistin gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "was"

Phrase: "also"

Phrase: "sequenced in 25 of the 75 type 2 diabetic patients,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0441730:Type 2 [Classification]
   741   C1550335:Patient type [Classification]
   739   C0030705:Patients [Patient or Disabled Group]
   739   C0241863:DIABETIC [Finding]
   739   C0332307:Type [Qualitative Concept]
   739   C1547052:*Type [Quantitative Concept]
   706   C0004793:Sequence [Nucleotide Sequence]
   706   C0162326:Sequence [Nucleotide Sequence]
   706   C0162327:Sequence [Nucleotide Sequence]
   706   C1519249:Sequence [Functional Concept]

Phrase: "in addition to the initial screening,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0220908:Screening [Health Care Activity]
   861   C0220909:screening [Functional Concept]
   861   C1698960:screening [Intellectual Product]
   861   C1710031:Screening [Diagnostic Procedure]
   861   C1710477:SCREENING [Research Activity]

Phrase: "which"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "24 patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.49: No other SNPs were detected in these patients, suggesting that most of all the SNPs, at least those with relatively high frequencies, were identified in this study. 

Phrase: "No"

Phrase: "other SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "detected in these patients,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that most of all"

Phrase: "the SNPs,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "those with relatively high frequencies,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   773   C0205212:High frequency [Temporal Concept]
   760   C0205250:High [Qualitative Concept]
   760   C0439603:Frequencies [Temporal Concept]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]
   726 E C0376249:frequency [Quantitative Concept]
   726 E C0871396:Frequency [Quantitative Concept]
   726 E C1561548:Frequency [Qualitative Concept]
   726 E C1705502:Frequency [Quantitative Concept]

Phrase: "were"

Phrase: "identified in this study."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205396:Identified [Qualitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C2603343:Study [Research Activity]
Processing 00000000.tx.50: Our findings show that Japanese subjects had two major haplotypes determined by -167C>T and +299G>A, namely CG and CA. 

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that Japanese subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "had"

Phrase: "two major haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "determined by -167C"

Phrase: ">T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and +"

Phrase: "299G"

Phrase: ">A,"

Phrase: "namely CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "and"

Phrase: "CA."
Processing 00000000.tx.51: Similarly, Japanese subjects had two major haplotypes determined by +157C>T and +299G>A, namely CG and CA. 

Phrase: "Similarly,"

Phrase: "Japanese subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "had"

Phrase: "two major haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "determined by +157C"

Phrase: ">T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and +"

Phrase: "299G"

Phrase: ">A,"

Phrase: "namely CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "and"

Phrase: "CA."
Processing 00000000.tx.52: Among the haplotypes defined by the three SNPs, two major haplotypes (CCG and CCA) were detected in Japanese subjects. 

Phrase: "Among the haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "defined by the three SNPs,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   814   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   748   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0032529:polymorphisms [Genetic Function]
   748   C0037179:Single [Population Group]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   748   C0205449:Three [Quantitative Concept]
   748   C1704788:Defined [Conceptual Entity]
   748   C3539106:Defined [Intellectual Product]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "two major haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "(CCG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516476:CCG [Health Care Related Organization]

Phrase: "and"

Phrase: "CCA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220668:CCA [Congenital Abnormality]

Phrase: "were"

Phrase: "detected in Japanese subjects."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1556094:Japanese [Population Group]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.53: Because most Japanese subjects had C at both -167 and +157, the +299G>A represents a simple potential marker for roughly classifying these two major haplotypes. 

Phrase: "Because"

Phrase: "most Japanese subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "had"

Phrase: "C at both -167"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1553033:[c] [Quantitative Concept]

Phrase: "and +"

Phrase: "157,"

Phrase: "the +299G"

Phrase: ">A"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a simple potential marker for roughly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0005516:Marker [Clinical Attribute]

Phrase: "classifying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008902:classifying [Classification]

Phrase: "these two major haplotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]
Processing 00000000.tx.54: The +299G>A SNP would be useful in searching for an association with specific phenotypes in Japanese type 2 diabetes, especially in cases where a large number of samples is involved. 

Phrase: "The +299G"

Phrase: ">"

Phrase: "A SNP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0752046:SNP [Nucleotide Sequence]
  1000   C1527094:SNP [Conceptual Entity]

Phrase: "would"

Phrase: "be"

Phrase: "useful in searching"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   718   C0042153:use [Functional Concept]
   718   C0457083:Use [Functional Concept]
   718   C1947944:Use [Intellectual Product]

Phrase: "for an association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with specific phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031437:Phenotypes [Organism Attribute]
   827 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "in Japanese type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0011860:Type 2 Diabetes [Disease or Syndrome]
   875   C1320657:type diabetes [Finding]
   861   C0441730:Type 2 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "especially in cases where"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "a large number of samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "is"

Phrase: "involved."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]
Processing 00000000.tx.55: Our findings demonstrate the lack of evidence for a major effect of resistin gene polymorphisms on susceptibility to type 2 diabetes. 

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "demonstrate"

Phrase: "the lack of evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "for a major effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "of resistin gene polymorphisms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0678951:gene polymorphisms [Genetic Function]
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "on susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0012655:Susceptibility [Clinical Attribute]
  1000   C0220898:Susceptibility [Organism Attribute]
  1000   C1264642:Susceptibility [Functional Concept]
  1000   C1547045:*Susceptibility [Quantitative Concept]
   928 E C0231204:Susceptible [Functional Concept]
   928 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "to type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.56: It should be noted that a small effect of these polymorphisms on susceptibility cannot be excluded, since the sample size was limited in the present study. 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "a small effect of these polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0012655:Susceptibility [Clinical Attribute]
  1000   C0220898:Susceptibility [Organism Attribute]
  1000   C1264642:Susceptibility [Functional Concept]
  1000   C1547045:*Susceptibility [Quantitative Concept]
   928 E C0231204:Susceptible [Functional Concept]
   928 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "cannot"

Phrase: "be"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: ","

Phrase: "since"

Phrase: "the sample size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242618:Sample Size [Quantitative Concept]
   861   C0456389:size [Spatial Concept]

Phrase: "was"

Phrase: "limited in the present study."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0150312:Present [Quantitative Concept]
   760   C0439801:Limited [Functional Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]
   760   C3542948:Limited [Intellectual Product]
   726 E C1549649:Limit [Idea or Concept]
   726 E C2349209:Limit [Conceptual Entity]
Processing 00000000.tx.57: It is known that Japanese subjects gain less weight than Caucasians as the result of lower insulin response (6,7). 

Phrase: "It"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that Japanese subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "gain"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "less weight than Caucasians"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0005910:weight [Organism Attribute]
   770   C0043100:Weight [Quantitative Concept]
   770   C1305866:weight [Diagnostic Procedure]
   770   C1705104:Weight [Idea or Concept]

Phrase: "as the result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of lower insulin response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.58: In fact, the mean BMI of type 2 diabetic patients examined was similar to that of normal control subjects. 

Phrase: "In fact,"

Phrase: "the mean BMI of type 2 diabetic patients"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "was"

Phrase: "similar to that of normal control subjects."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.59: Because the serum resistin levels are increased in obese insulin-resistant rodents, the resistin gene may well be involved in the development of type 2 diabetes associated with severe obesity. 

Phrase: "Because"

Phrase: "the serum resistin levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "increased in obese insulin-resistant rodents,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   783   C0020459:increased insulin [Disease or Syndrome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0028754:Obese [Disease or Syndrome]
   753   C0035804:Rodents [Mammal]
   753   C0205217:Increased [Quantitative Concept]
   753   C0332325:Resistant [Functional Concept]
   753   C0442805:Increased [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "the resistin gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "may"

Phrase: "well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "be"

Phrase: "involved in the development of type 2 diabetes"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   800   C0011860:Type 2 Diabetes [Disease or Syndrome]
   770   C0441730:Type 2 [Classification]
   767   C1320657:Diabetes type [Finding]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0243107:development [Physiologic Function]
   744   C0332307:Type [Qualitative Concept]
   744   C0678723:Development [Organism Function]
   744   C1314939:Involved [Functional Concept]
   744   C1527148:Development [Functional Concept]
   744   C1547052:*Type [Quantitative Concept]

Phrase: "associated with severe obesity."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0028756:Obesity, Severe [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0028754:Obesity [Disease or Syndrome]
   770   C0205082:Severe [Qualitative Concept]
   770   C1963185:Obesity [Finding]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.60: Another molecule might be present in the human as a functional homologue of the mouse resistin, since the homology between human and mouse resistin genes is low. 

Phrase: "Another molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:Molecule [Substance]
   928 E C1521991:Molecular [Qualitative Concept]

Phrase: "might"

Phrase: "be"

Phrase: "present in the human"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "as a functional homologue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1334043:Homologue [Gene or Genome]

Phrase: "of the mouse resistin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1567876:resistin, mouse [Amino Acid, Peptide, or Protein,Hormone]
   861   C0963992:resistin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1426906:RESISTIN [Gene or Genome]

Phrase: "since"

Phrase: "the homology between human"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1334043:Homology [Gene or Genome]
   770   C2697616:Homology [Qualitative Concept]

Phrase: "and"

Phrase: "mouse resistin genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017337:Genes [Gene or Genome]
   734   C1567876:resistin, mouse [Amino Acid, Peptide, or Protein,Hormone]

Phrase: "is"

Phrase: "low."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]
Processing 00000000.tx.61: Steppan et al. 

Phrase: "Steppan et al."
Processing 00000000.tx.62: (8) reported on a family of resistin-like molecules (RELMs) in rodents and humans. 

Phrase: "(8"

Phrase: ")"

Phrase: "reported on a family of resistin-like molecules (RELMs)"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   744   C0015576:Family [Family Group]
   744   C0567416:molecules [Substance]
   744   C0684224:Reported [Intellectual Product]
   744   C0700287:Reported [Health Care Activity]
   744   C0963992:resistin [Amino Acid, Peptide, or Protein,Hormone]
   744   C1426906:RESISTIN [Gene or Genome]
   744   C1704727:Family [Conceptual Entity]
   744   C3496591:Reported [Clinical Attribute]
   711 E C3273238:Report [Intellectual Product]

Phrase: "in rodents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035804:Rodents [Mammal]

Phrase: "and"

Phrase: "humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.63: RELM is expressed most abundantly in adipose tissue, and RELM is expressed only in the gastrointestinal tract. 

Phrase: "RELM"

Phrase: "is"

Phrase: "expressed"

Phrase: "most abundantly in adipose tissue,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0001527:Adipose tissue [Tissue]
   760   C0040300:Tissue [Tissue]
   760   C0205393:Most [Quantitative Concept]
   760   C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "RELM"

Phrase: "is"

Phrase: "expressed"

Phrase: "only in the gastrointestinal tract."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0017189:Gastrointestinal Tract [Body System]
   806   C1281182:Gastrointestinal tract [Body System]
   760   C0205171:Only [Quantitative Concept]
   760   C0521362:gastrointestinal [Spatial Concept]
   760   C1185740:Tract [Body Part, Organ, or Organ Component]
   760   C1720467:Only [Intellectual Product]
Processing 00000000.tx.64: Resistin and the RELMs share a cysteine composition and other signature features, suggesting that these molecules comprise a class of tissue-specific signaling molecules. 

Phrase: "Resistin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0963992:resistin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1426906:RESISTIN [Gene or Genome]

Phrase: "and"

Phrase: "the RELMs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0567416:molecules [Substance]
   827   C0963992:resistin [Amino Acid, Peptide, or Protein,Hormone]
   827   C1426906:RESISTIN [Gene or Genome]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "a cysteine composition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0486616:Composition [Clinical Attribute]
   861   C1555710:composition [Idea or Concept]

Phrase: "and"

Phrase: "other signature features,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]

Phrase: "comprise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "a class of tissue-specific signaling molecules."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0456387:Class [Intellectual Product]
   748   C1705943:Class [Classification]
Processing 00000000.tx.65: Further investigation will be required for the regulation of resistin gene expression in obese rodents and the effect of thiazolidinediones. 

Phrase: "Further investigation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C1261322:Investigation [Health Care Activity]
   861   C1552578:investigation [Idea or Concept]
   789 E C1517586:Investigational [Qualitative Concept]
   789 E C3245491:investigational [Intellectual Product]

Phrase: "will"

Phrase: "be"

Phrase: "required for the regulation of resistin gene expression"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   819   C0017263:Regulation of Gene Expression [Genetic Function]
           Gene Expression Regulation
           Gene Regulation
   770   C0017262:Gene Expression [Genetic Function]
   744   C0017337:Gene [Gene or Genome]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C0963992:resistin [Amino Acid, Peptide, or Protein,Hormone]
   744   C1327622:Regulation [Biologic Function]
   744   C1426906:RESISTIN [Gene or Genome]
   744   C1514873:Required [Functional Concept]

Phrase: "in obese rodents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035804:Rodents [Mammal]

Phrase: "and"

Phrase: "the effect of thiazolidinediones."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.66: Serum resistin levels are increased in obese insulin resistant ob/ob and db/db mice (5). 

Phrase: "Serum resistin levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "increased in obese insulin resistant ob/ob"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C0020459:increased insulin [Disease or Syndrome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0028754:Obese [Disease or Syndrome]
   748   C0205217:Increased [Quantitative Concept]
   748   C0332325:Resistant [Functional Concept]
   748   C0442805:Increased [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "and"

Phrase: "db/db mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.67: Rosiglitazone reduces serum resistin levels in mice. 

Phrase: "Rosiglitazone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0289313:rosiglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "reduces"

Phrase: "serum resistin levels in mice."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.68: Rosiglitazone also decreases resistin gene expression in 3T3-L1 adipocytes. 

Phrase: "Rosiglitazone also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0289313:rosiglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "resistin gene expression in 3T3-L1 adipocytes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0017262:Gene Expression [Genetic Function]
   748   C0017337:Gene [Gene or Genome]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.69: Recently, Way et al. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "Way et al."
Processing 00000000.tx.70: (9) showed that resistin gene expression is decreased in the white adipose tissue of obesity models, such as ob/ob, db/db, tub/tub, and KKAy mice. 

Phrase: "(9"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that resistin gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0017262:Gene Expression [Genetic Function]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "decreased in the white adipose tissue of obesity models,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   790   C1704223:White Adipose Tissue [Tissue]
   764   C0001527:Adipose tissue [Tissue]
   745   C1519523:Tissue Model [Experimental Model of Disease]
   742   C0007457:White [Population Group]
   742   C0028754:Obesity [Disease or Syndrome]
   742   C0040300:Tissue [Tissue]
   742   C0043157:White [Population Group]
   742   C0205216:Decreased [Quantitative Concept]
   742   C0220938:White [Qualitative Concept]
   742   C0392756:Decreased [Qualitative Concept]
   742   C0442797:decreased [Qualitative Concept]
   742   C1547928:Tissue [Intellectual Product]
   742   C1963185:Obesity [Finding]
   742   C3161035:Models [Intellectual Product]
   708 E C0547047:Decrease [Quantitative Concept]

Phrase: "such as ob/ob,"

Phrase: "db/db,"

Phrase: "tub/tub,"

Phrase: "and"

Phrase: "KKAy mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.71: Several different classes of PPAR- agonists cause an increase in resistin expression in adipose tissue of both ob/ob mice and Zucker fatty rats. 

Phrase: "Several different classes of PPAR-"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0439064:Several [Quantitative Concept]
   748   C0443302:Several [Quantitative Concept]
   748   C0456387:Class [Intellectual Product]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0752063:Peroxysome [Cell Component]
   748   C1705242:Different [Qualitative Concept]
   748   C1705943:Class [Classification]
   748   C2984308:Peroxisome [Functional Concept]
   738   C0684000:class differences [Finding]

Phrase: "agonists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243192:agonists [Pharmacologic Substance]
  1000   C2987634:agonists [Pharmacologic Substance]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "an increase in resistin expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "in adipose tissue"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001527:Adipose tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   789   C0028754:Adiposity [Disease or Syndrome]
   789   C1563743:adiposity [Organism Attribute]

Phrase: "of both ob/ob mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "Zucker fatty rats."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]
Processing 00000000.tx.72: In summary, we report here on a systematic search for SNPs in the resistin gene and the identification of three intronic SNPs. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "here on a systematic search"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220922:systematic [Functional Concept]
   760   C1552603:search [Intellectual Product]
   760   C1706202:Search [Activity]

Phrase: "for SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "in the resistin gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "the identification of three intronic SNPs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0020792:Identification [Mental Process]
   744   C0205396:Identification [Qualitative Concept]
Processing 00000000.tx.73: No association of these SNPs or haplotypes defined by these SNPs in linkage disequilibrium with type 2 diabetes was evident. 

Phrase: "No association of these SNPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "or"

Phrase: "haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "defined by these SNPs"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   753   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0032529:polymorphisms [Genetic Function]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C1704788:Defined [Conceptual Entity]
   753   C3539106:Defined [Intellectual Product]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "in linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "with type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "was"

Phrase: "evident."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.74: The issue of how these SNPs affect resistin gene expression in adipocytes and its serum levels, and whether SNPs in resistin gene are associated with type 2 diabetes in other ethnic groups, remains unclear. 

Phrase: "The issue of how"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033213:Issue [Finding]
   770   C1706387:Issue [Intellectual Product]

Phrase: "these SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "resistin gene expression in adipocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0017262:Gene Expression [Genetic Function]
   760   C0017337:Gene [Gene or Genome]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "its serum levels,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0229671:Serum [Body Substance]
   861   C0441889:Levels [Qualitative Concept]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "whether"

Phrase: "SNPs in resistin gene"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   783   C0678951:gene polymorphisms [Genetic Function]
   753   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0032529:polymorphisms [Genetic Function]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "are"

Phrase: "associated with type 2 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in other ethnic groups,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0015031:Ethnic Groups [Population Group]
           ETHNIC
   966 E C1879937:Ethnic Group [Intellectual Product]
   861   C0441833:Group [Idea or Concept]
   861   C0680174:ethnic [Finding]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "remains"

Phrase: "unclear."
Processing 00000000.tx.75: Further study will be required to clarify these points.  

Phrase: "Further study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "will"

Phrase: "be"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "these points."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1552961:Point [Quantitative Concept]
   966   C2347617:point [Quantitative Concept]
Processing 00000000.tx.76: RESEARCH DESIGN AND METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS REFERENCES  This study involved an initial screening of 24 unrelated type 2 diabetic outpatients from the Ehime University Hospital and the Ehime Prefectural Hospital. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   876   C0086912:methods research [Research Activity]
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "an initial screening of 24 unrelated type 2 diabetic outpatients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   739   C0220908:Screening [Health Care Activity]
   739   C0220909:screening [Functional Concept]
   739   C1698960:screening [Intellectual Product]
   739   C1710031:Screening [Diagnostic Procedure]
   739   C1710477:SCREENING [Research Activity]

Phrase: "from the Ehime University Hospital"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0020028:university hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1510665:Hospital [Qualitative Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "and"

Phrase: "the Ehime Prefectural Hospital."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C1510665:Hospital [Qualitative Concept]
   743 E C1609061:Hospitals [Intellectual Product]
Processing 00000000.tx.77: The subjects were chosen based on the fact that they showed the typical characteristics of type 2 diabetes, namely, age of onset between 40 and 60 years, treatment with diet alone or oral hypoglycemic agents, and the presence of first-degree relatives with type 2 diabetes. 

Phrase: "The subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "chosen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]

Phrase: "based on the fact"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "that"

Phrase: "they"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the typical characteristics of type 2 diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C3645613:Characteristic type [Intellectual Product]
   748   C1521970:Characteristics [Qualitative Concept]

Phrase: "namely,"

Phrase: "age of onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   790   C0001779:Age [Organism Attribute]

Phrase: "between 40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "and"

Phrase: "60 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "treatment with diet"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or"

Phrase: "oral hypoglycemic agents,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0359086:HYPOGLYCEMIC AGENTS, ORAL [Pharmacologic Substance]
           Oral hypoglycaemic
   901   C0020616:Hypoglycemic Agents [Pharmacologic Substance]
           Hypoglycaemic
   827   C0442027:Oral [Spatial Concept]
   793   C0450442:Agent [Chemical Viewed Functionally]
   793   C1254351:Agent [Pharmacologic Substance]
   793   C1521826:Agent [Intellectual Product]

Phrase: "and"

Phrase: "the presence of first-degree relatives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "with type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.78: Diabetes was diagnosed based on the American Diabetes Association criteria, reported in 1998 (10). 

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "was"

Phrase: "diagnosed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]

Phrase: "based on the American Diabetes Association criteria,"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   814   C1705019:American Diabetes Association [Professional Society]
   748   C0004083:Association [Mental Process]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0243161:criteria [Intellectual Product]
   748   C0439849:Association [Qualitative Concept]
   748   C0596070:American [Population Group]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]
   748   C1527178:Based [Functional Concept]
   748   C1705938:Based [Idea or Concept]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1880279:Base [Biomedical or Dental Material]

Phrase: "reported in 1998"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.79: The entire resistin gene was initially sequenced in these 24 diabetic patients. 

Phrase: "The entire resistin gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "was"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "sequenced in these 24 diabetic patients."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0241863:DIABETIC [Finding]
   719   C0004793:Sequence [Nucleotide Sequence]
   719   C0162326:Sequence [Nucleotide Sequence]
   719   C0162327:Sequence [Nucleotide Sequence]
   719   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.80: For the association study, the regions containing the SNPs identified were sequenced in 75 additional unrelated type 2 diabetic subjects and 99 nondiabetic subjects. 

Phrase: "For the association study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "the regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "were"

Phrase: "sequenced in 75 additional unrelated type 2 diabetic subjects"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   764   C0441730:Type 2 [Classification]
   742   C0241863:DIABETIC [Finding]
   742   C0332307:Type [Qualitative Concept]
   742   C0445356:Unrelated [Finding]
   742   C1524062:Additional [Functional Concept]
   742   C1547052:*Type [Quantitative Concept]
   742   C1704623:Unrelated [Qualitative Concept]
   708   C0004793:Sequence [Nucleotide Sequence]
   708   C0162326:Sequence [Nucleotide Sequence]
   708   C0162327:Sequence [Nucleotide Sequence]
   708   C0681850:Subject [Group]
   708   C1519249:Sequence [Functional Concept]
   708   C1550501:{Subject} [Idea or Concept]
   708   C1706203:Subject [Idea or Concept]
   708   C2349001:Subject [Human]
   708   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "99 nondiabetic subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]
Processing 00000000.tx.81: To confirm that SNPs, at least those with relatively high frequencies, were identified in the initial screening, the entire resistin gene was also sequenced in 25 patients randomly chosen from these 75 type 2 diabetic subjects. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that SNPs,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "those with relatively high frequencies,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   773   C0205212:High frequency [Temporal Concept]
   760   C0205250:High [Qualitative Concept]
   760   C0439603:Frequencies [Temporal Concept]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]
   726 E C0376249:frequency [Quantitative Concept]
   726 E C0871396:Frequency [Quantitative Concept]
   726 E C1561548:Frequency [Qualitative Concept]
   726 E C1705502:Frequency [Quantitative Concept]

Phrase: "were"

Phrase: "identified in the initial screening,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   760   C0205265:Initial [Temporal Concept]
   760   C0205396:Identified [Qualitative Concept]
   760   C0220908:Screening [Health Care Activity]
   760   C0220909:screening [Functional Concept]
   760   C1279901:Initial [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1555582:Initial [Idea or Concept]
   760   C1698960:screening [Intellectual Product]
   760   C1705685:INITIAL [Functional Concept]
   760   C1710031:Screening [Diagnostic Procedure]
   760   C1710477:SCREENING [Research Activity]

Phrase: "the entire resistin gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "was"

Phrase: "also"

Phrase: "sequenced in 25 patients randomly"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0030705:Patients [Patient or Disabled Group]
   726   C0004793:Sequence [Nucleotide Sequence]
   726   C0162326:Sequence [Nucleotide Sequence]
   726   C0162327:Sequence [Nucleotide Sequence]
   726   C1519249:Sequence [Functional Concept]

Phrase: "chosen from these 75 type 2 diabetic subjects."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0441730:Type 2 [Classification]
   744   C0241863:DIABETIC [Finding]
   744   C0332307:Type [Qualitative Concept]
   744   C1547052:*Type [Quantitative Concept]
   744   C1707391:Chosen [Activity]
   711   C0681850:Subject [Group]
   711   C1550501:{Subject} [Idea or Concept]
   711   C1706203:Subject [Idea or Concept]
   711   C2349001:Subject [Human]
   711   C2697811:Subject [Functional Concept]
Processing 00000000.tx.82: The 99 nondiabetic control subjects were chosen based on the fact that they had no history of diabetes, an absence of diabetic patients among their first-degree relatives, and normal glucose tolerance, as evidenced by a 75-g oral glucose tolerance test. 

Phrase: "The 99 nondiabetic control subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "chosen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]

Phrase: "based on the fact"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "that"

Phrase: "they"

Phrase: "had"

Phrase: "no history of diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   909   C0332122:No history of [Qualitative Concept]
   770   C0019664:History [Occupation or Discipline]
   770   C0019665:history [Intellectual Product]
   770   C0262512:History, NOS [Organism Attribute]
   770   C0262926:History [Finding]
   770   C1705255:History [Conceptual Entity]
   770   C2004062:History [Finding]

Phrase: "an absence of diabetic patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "among their first-degree relatives,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
  1000   C1518469:First Degree Relatives [Quantitative Concept]
   966 E C1517194:First Degree Relative [Family Group]
   901   C0444502:First degree [Qualitative Concept]
   827   C0080103:Relatives [Family Group]
   827   C0205435:First [Quantitative Concept]
   827   C0441889:Degree [Qualitative Concept]
   827   C0449286:Degree [Quantitative Concept]
   827   C0542560:Degree [Intellectual Product]
   827   C1279901:First [Qualitative Concept]
   827   C1561545:degree [Quantitative Concept]
   827   C2348088:Degree [Quantitative Concept]
   793 E C0205345:Relative [Qualitative Concept]
   793 E C1547039:*Relative [Quantitative Concept]

Phrase: "and"

Phrase: "normal glucose tolerance,"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   901   C0178665:Glucose tolerance [Physiologic Function]
   901   C0860800:normal glucose [Finding]
   827   C0013220:Tolerance [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0020963:Tolerance [Pathologic Function]
   827   C0205307:Normal [Qualitative Concept]
   827   C0220929:tolerance [Mental Process]
   827   C0231197:Tolerance [Physiologic Function]
   827   C0439166:% normal [Quantitative Concept]
   827   C1704410:Tolerance [Qualitative Concept]
   827   C2347086:% Normal [Quantitative Concept]
   771 E C0680282:toleration [Social Behavior]
   755 E C0231198:Tolerant [Functional Concept]

Phrase: "as"

Phrase: "evidenced by a 75-g oral glucose tolerance test."
Meta Candidates (Total=23; Excluded=0; Pruned=0; Remaining=23)
   818   C0029161:Oral Glucose Tolerance Test [Diagnostic Procedure]
           Oral Glucose Tolerance
   790   C0017741:Glucose tolerance test [Diagnostic Procedure]
   784   C0201778:Tolerance test, oral [Laboratory Procedure]
   764   C0178665:Glucose tolerance [Physiologic Function]
   764   C0201777:Tolerance test [Laboratory Procedure]
   764   C1979839:75 g [Quantitative Concept]
   762   C0337438:glucose test [Laboratory Procedure]
   762   C0595310:GLUCOSE TEST [Medical Device]
   762   C0597140:oral tolerance [Organism Attribute]
   762   C1955477:Glucose (oral) [Clinical Attribute]
   742   C0013220:Tolerance [Finding]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0020963:Tolerance [Pathologic Function]
   742   C0022885:Test [Laboratory Procedure]
   742   C0039593:Test [Functional Concept]
   742   C0220929:tolerance [Mental Process]
   742   C0231197:Tolerance [Physiologic Function]
   742   C0392366:test [Intellectual Product]
   742   C0439267:g% [Quantitative Concept]
   742   C0442027:Oral [Spatial Concept]
   742   C1704410:Tolerance [Qualitative Concept]
   708   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.83: All patients and control subjects were informed of the purpose of the study, and their consent was obtained. 

Phrase: "All patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "informed of the purpose of the study,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   800   C0681832:purpose of study [Research Activity]
   748   C0557651:Study [Manufactured Object]
   748   C1285529:Purpose [Functional Concept]
   748   C1522154:Informed [Qualitative Concept]
   748   C2603343:Study [Research Activity]
   714 E C0537670:Inform [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   714 E C0700287:inform [Health Care Activity]
   714 E C1552002:inform [Idea or Concept]

Phrase: "and"

Phrase: "their consent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511481:Consent [Functional Concept]
  1000   C1554192:consent [Idea or Concept]

Phrase: "was"

Phrase: "obtained."
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.84: The study was approved by the ethics committee of the Ehime University Hospital and Ehime Prefectural Hospital. 

Phrase: "The study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "approved by the ethics committee of the Ehime University Hospital"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   777   C0086021:Hospital Ethics Committee [Professional or Occupational Group]
   760   C0020028:university hospital [Health Care Related Organization,Manufactured Object]
   760   C0085546:Ethics Committee [Professional or Occupational Group]
   757   C1136380:Ethics, Hospital [Idea or Concept]
   739   C0015000:Ethics [Idea or Concept]
   739   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   739   C0041740:University [Manufactured Object,Organization]
   739   C0205540:Approved [Qualitative Concept]
   739   C1510665:Hospital [Qualitative Concept]
   739   C1527243:ethics [Idea or Concept]
   739   C2699414:Committee [Group]

Phrase: "and"

Phrase: "Ehime Prefectural Hospital."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C1510665:Hospital [Qualitative Concept]
   743 E C1609061:Hospitals [Intellectual Product]
Processing 00000000.tx.85: The clinical characteristics of the 99 type 2 diabetic subjects and the 99 control subjects are summarized in Table 2. 

Phrase: "The clinical characteristics of the 99 type 2 diabetic subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0683325:clinical characteristics [Clinical Attribute]
   741   C0681884:subject characteristics [Research Activity]
   741   C1519021:Subject Characteristics [Organism Attribute]
   741   C1706465:Subject Characteristics [Idea or Concept]
   741   C3645613:Characteristic type [Intellectual Product]
   739   C1521970:Characteristics [Qualitative Concept]

Phrase: "and"

Phrase: "the 99 control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "are"

Phrase: "summarized in Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.86: The age of the control subjects was comparable to the age of onset of the type 2 diabetic subjects. 

Phrase: "The age of the control subjects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C2348575:Subject Age [Organism Attribute]
   753   C0001779:Age [Organism Attribute]

Phrase: "was"

Phrase: "comparable to the age of onset of the type 2 diabetic subjects."
Processing 00000000.tx.87: PCR direct sequencing was performed as described previously (11,12). 

Phrase: "PCR direct sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1553778:Sequencing [Intellectual Product]
   827   C1561491:Sequencing [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.88: Genomic DNA was extracted from leukocytes using a DNA Isolation Kit for Mammalian Blood (Boehringer Mannheim, Indianapolis, IN). 

Phrase: "Genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "was"

Phrase: "extracted from leukocytes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0023516:Leukocytes [Cell]
   790   C0185115:Extracted [Therapeutic or Preventive Procedure]
   790   C3541890:EXTRACTED [Finding]
   756 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a DNA Isolation Kit for Mammalian Blood"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0812225:KIT [Medical Device]
   748   C1150635:KIT [Molecular Function]
   748   C1705212:Kit [Medical Device]
   748   C1705213:KIT [Medical Device]
   748   C3273202:Kit [Manufactured Object]

Phrase: "(Boehringer Mannheim,"

Phrase: "Indianapolis,"

Phrase: "IN"

Phrase: ")."
Processing 00000000.tx.89: The 5' flanking region and three exons, as well as the introns of the resistin gene, were individually amplified using primers, as described in Table 1. 

Phrase: "The 5' flanking region"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0949645:5' Flanking Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   913   C1883644:5' Region [Nucleotide Sequence]
           5' Flank
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   827   C0230171:flanking [Body Location or Region]
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "three exons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as well as"

Phrase: "the introns of the resistin gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0021920:Introns [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "individually"

Phrase: "amplified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as"

Phrase: "described in Table 1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1552738:described [Idea or Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.90: The PCR between +691 and +854 were not feasible, probably because of the long region of repetitive C bases, although different sets of primers in this region were tested. 

Phrase: "The PCR between +691"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]

Phrase: "and +"

Phrase: "854"

Phrase: "were"

Phrase: "not feasible, probably because of the long region of repetitive C bases,"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   751   C0086908:Repetitive Region [Nucleotide Sequence]
   736   C0017446:Region [Geographic Area]
   736   C0178499:bases [Chemical Viewed Functionally]
   736   C0205147:Region [Spatial Concept]
   736   C0205166:Long [Qualitative Concept]
   736   C0750492:Probably [Idea or Concept]
   736   C1518422:Not [Functional Concept]
   736   C1626935:Bases [Quantitative Concept]
   736   C1706317:Long [Qualitative Concept]
   703 E C0002055:base [Inorganic Chemical]
   703 E C1527178:Basis [Functional Concept]
   703 E C1874451:Basis [Pharmacologic Substance]
   703 E C1880279:Base [Biomedical or Dental Material]

Phrase: "although"

Phrase: "different sets of primers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0036849:Set [Mental Process]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]

Phrase: "in this region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "were"

Phrase: "tested."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.91: We amplified 30 ng of genomic DNA in a 15 l reaction mixture, which included 0.375 units of Taq DNA polymerase (Takara Shuzo Biomedical Group, Shiga, Japan), 3 pmoles of each primer, 3 nmoles of each dNTP, and 5% DMSO. 

Phrase: "We"

Phrase: "amplified"

Phrase: "30 ng of genomic DNA"

Phrase: "in a 15 l reaction mixture,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439962:Mixture [Substance]

Phrase: "which"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "0.375 units of Taq DNA polymerase"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0439148:Units [Quantitative Concept]
   748   C1519795:Units [Quantitative Concept]
   714 E C1704753:Unit [Manufactured Object]
   714 E C1880519:Unit [Quantitative Concept]

Phrase: "(Takara Shuzo Biomedical Group,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "Shiga,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "3 pmoles of each primer,"

Phrase: "3 nmoles of each dNTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439191:NMOLE [Quantitative Concept]

Phrase: "and"

Phrase: "5% DMSO."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012403:DMSO [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.92: After the first denaturing for 3 min at 94C, PCR was carried out for 30 cycles, with denaturing at 94C for 30 s, annealing at 55C for 30 s, and extension at 72C for 1 min, with a final extension period of 3 min. 

Phrase: "After the first denaturing"

Phrase: "for 3 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 94C,"

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out for 30 cycles,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]
   737   C1511572:Cycle [Temporal Concept]

Phrase: "with denaturing"

Phrase: "at 94C"

Phrase: "for 30 s,"

Phrase: "annealing at 55C"

Phrase: "for 30 s,"

Phrase: "and"

Phrase: "extension at 72C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0231448:Extension [Functional Concept]
   790   C1880641:Extension [Conceptual Entity]

Phrase: "for 1 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "with a final extension period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   755 E C0332182:Periodic [Temporal Concept]
   755 E C1706381:PERIODIC [Intellectual Product]
   727 E C0031084:Periodicities [Temporal Concept]

Phrase: "of 3 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.93: The amplified PCR products were electrophoresed on a 1% agarose gel and then stained with Cyber Green I (BioWhittaker Molecular Application, Rockland, ME) to confirm the size of each molecule. 

Phrase: "The amplified PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "electrophoresed on a 1% agarose gel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1706746:Agarose Gel [Research Device]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0036681:Agarose [Carbohydrate]
   753   C1382104:Gel [Substance]
   719   C0013855:electrophorese [Laboratory Procedure]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stained with Cyber Green I (BioWhittaker Molecular Application,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   744   C0021966:I- [Inorganic Chemical]
   744   C0185125:Application [Health Care Activity]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0332583:Green [Qualitative Concept]
   744   C1521991:Molecular [Qualitative Concept]
   744   C1947919:Application [Intellectual Product]
   744   C2347934:Application [Intellectual Product]
   744   C2986582:Stained [Qualitative Concept]
   744   C3539080:APPLICATION [Quantitative Concept]
   711 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "Rockland,"

Phrase: "ME) to"

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the size of each molecule."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0596969:molecular size [Quantitative Concept]
   760   C0456389:size [Spatial Concept]
Processing 00000000.tx.94: These PCR products were sequenced using forward and/or reverse primers, after purification using a Multiscreen PCR filter (Millipore, Bedford, MA). 

Phrase: "These PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: "and/or"

Phrase: "reverse primers,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "after"

Phrase: "purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Multiscreen PCR filter"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0180860:Filter [Manufactured Object]
   827   C0581406:Filter [Medical Device]
   827   C1522664:Filter [Intellectual Product]
   827   C1704449:Filter [Conceptual Entity]
   827   C1704684:Filter [Medical Device]
   827   C1875155:FILTER [Medical Device]

Phrase: "(Millipore,"

Phrase: "Bedford,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.95: The sequencing reaction was carried out using Taq Dye Deoxy and ABI Prism terminator cycle sequencing kits (Applied Biosystems, Perkin-Elmer, Foster City, CA). 

Phrase: "The sequencing reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Taq Dye"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]

Phrase: "Deoxy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069851:dE-oxy [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "ABI Prism terminator cycle sequencing kits"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   799   C1690540:Kits [Qualitative Concept]
   766 E C0812225:KIT [Medical Device]
   766 E C1150635:KIT [Molecular Function]
   766 E C1705212:Kit [Medical Device]
   766 E C1705213:KIT [Medical Device]
   766 E C3273202:Kit [Manufactured Object]

Phrase: "(Applied Biosystems,"

Phrase: "Perkin-Elmer,"

Phrase: "Foster City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA)."
Processing 00000000.tx.96: The products were then purified using either an Autoseq G-50 column (Amersham Pharmacia Biotech, Piscataway, NJ) or a Multiscreen HV plate (Millipore) loaded with Sephadex G-50 Superfine. 

Phrase: "The products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "either"

Phrase: "an Autoseq G-50 column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1185738:Column [Body Part, Organ, or Organ Component]
   812   C1706132:Column [Idea or Concept]

Phrase: "(Amersham Pharmacia Biotech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Piscataway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551491:Piscataway [Population Group]

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")"

Phrase: "or"

Phrase: "a Multiscreen HV plate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005971:Plate [Medical Device]
   827   C1139930:plate [Medical Device]
   827   C3537155:Plate [Manufactured Object]

Phrase: "(Millipore"

Phrase: ")"

Phrase: "loaded with Sephadex G-50 Superfine."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C1120001:sephadex G 50 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C1119999:sephadex G [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0074343:sephadex [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0439267:g% [Quantitative Concept]
   753   C1708715:Loaded [Activity]
   719 E C1550025:Load [Idea or Concept]
   719 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.97: These products were then electrophoresed on an ABI gene analyzer 3100 system (PE Applied Biosystems). 

Phrase: "These products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "electrophoresed on an ABI gene analyzer 3100 system"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0017337:Gene [Gene or Genome]
   744   C0179038:Analyzer [Medical Device]
   744   C0449913:System [Functional Concept]
   744   C1328319:ABI [Clinical Attribute]
   744   C1553451:System [Manufactured Object]
   744   C1704459:System [Medical Device]
   744   C1706246:Analyzer [Manufactured Object]
   711   C0013855:electrophorese [Laboratory Procedure]

Phrase: "(PE Applied Biosystems"

Phrase: ")."
Processing 00000000.tx.98: Both strands of the entire resistin gene were sequenced for the initial screening of the 24 type 2 diabetic subjects to detect any unknown SNPs. 

Phrase: "Both"

Phrase: "strands of the entire resistin gene"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0017337:Gene [Gene or Genome]
   753   C0439751:Entire [Quantitative Concept]
   753   C0444667:Entire [Quantitative Concept]
   753   C0963992:resistin [Amino Acid, Peptide, or Protein,Hormone]
   753   C1426906:RESISTIN [Gene or Genome]
   753   C1704972:Strand [Spatial Concept]
   753   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "sequenced for the initial screening of the 24 type 2 diabetic subjects to"
Meta Candidates (Total=22; Excluded=0; Pruned=0; Remaining=22)
   750   C0441730:Type 2 [Classification]
   735   C0205265:Initial [Temporal Concept]
   735   C0220908:Screening [Health Care Activity]
   735   C0220909:screening [Functional Concept]
   735   C0241863:DIABETIC [Finding]
   735   C0332307:Type [Qualitative Concept]
   735   C1279901:Initial [Qualitative Concept]
   735   C1547052:*Type [Quantitative Concept]
   735   C1555582:Initial [Idea or Concept]
   735   C1698960:screening [Intellectual Product]
   735   C1705685:INITIAL [Functional Concept]
   735   C1710031:Screening [Diagnostic Procedure]
   735   C1710477:SCREENING [Research Activity]
   702   C0004793:Sequence [Nucleotide Sequence]
   702   C0162326:Sequence [Nucleotide Sequence]
   702   C0162327:Sequence [Nucleotide Sequence]
   702   C0681850:Subject [Group]
   702   C1519249:Sequence [Functional Concept]
   702   C1550501:{Subject} [Idea or Concept]
   702   C1706203:Subject [Idea or Concept]
   702   C2349001:Subject [Human]
   702   C2697811:Subject [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "any unknown SNPs."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.99: A nested primer 5'-ATCATCATCATCTCCAGGT-3' was used as a reverse primer for exon 4 when GAT repeats affected the sequencing. 

Phrase: "A nested primer 5'-ATCATCATCATCTCCAGGT-3'"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "used as a reverse primer"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
   760   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1273517:used [Finding]
   760   C1555029:Reverse [Idea or Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "for exon 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "when"

Phrase: "GAT repeats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205341:repeats [Functional Concept]
   861   C1705914:Repeats [Conceptual Entity]
   827 E C1547730:Repeat [Temporal Concept]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the sequencing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1553778:Sequencing [Intellectual Product]
  1000   C1561491:Sequencing [Functional Concept]
Processing 00000000.tx.100: Sequences of a plus strand of intron 1 and a minus strand of intron 2, where the identified SNPs were located, were then checked for the association study because these strands allow the polymorphisms to be identified more precisely. 

Phrase: "Sequences of a plus strand of intron 1"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0162326:Sequences [Nucleotide Sequence]
   711 E C0004793:Sequence [Nucleotide Sequence]
   711 E C0162327:Sequence [Nucleotide Sequence]
   711 E C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "a minus strand of intron 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1704972:Strand [Spatial Concept]
   753   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "where"

Phrase: "the identified SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "located"

Phrase: ","

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "checked for the association study"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0557651:Study [Manufactured Object]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]
   760   C1283174:Checked [Activity]
   760   C2603343:Study [Research Activity]

Phrase: "because"

Phrase: "these strands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1704972:Strand [Spatial Concept]
   966   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "the polymorphisms to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "be"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "more precisely."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]
Processing 00000000.tx.101: The other strand was also sequenced, when required. 

Phrase: "The"

Phrase: "other strand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704972:Strand [Spatial Concept]
  1000   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "also"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: ","

Phrase: "when"

Phrase: "required."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]
Processing 00000000.tx.102: A 2 test was used for statistical analysis unless otherwise indicated. 

Phrase: "A 2 test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]

Phrase: "was"

Phrase: "used for statistical analysis"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0871424:statistical analysis [Research Activity]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0038215:Statistical [Occupation or Discipline]
   770   C0936012:Analysis [Research Activity]
   770   C1273517:used [Finding]
   770   C1524024:analysis [Functional Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "unless"

Phrase: "otherwise"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.103: Haplotype frequencies between two or three SNPs were estimated based on the EH program (13). 

Phrase: "Haplotype frequencies between two"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   770   C0439603:Frequencies [Temporal Concept]
   737 E C0376249:frequency [Quantitative Concept]
   737 E C0871396:Frequency [Quantitative Concept]
   737 E C1561548:Frequency [Qualitative Concept]
   737 E C1705502:Frequency [Quantitative Concept]

Phrase: "or"

Phrase: "three SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "based on the EH program"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C1520135:EH [Geographic Area]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C1709697:Program [Conceptual Entity]
   760   C2728259:Program [Pharmacologic Substance]
   760   C3484370:Program [Functional Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.104: The relative linkage disequilibrium value for two SNPs was defined as the ratio of the linkage disequilibrium parameter to the possible maximum linkage disequilibrium parameter (14). 

Phrase: "The relative linkage disequilibrium value for two SNPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0205345:Relative Value [Qualitative Concept]
   739   C1522609:Value [Quantitative Concept]

Phrase: "was"

Phrase: "defined as the ratio of the linkage disequilibrium parameter"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0023746:Linkage Disequilibrium [Quantitative Concept]
   742   C0023745:linkage [Molecular Function]
   742   C0281825:Disequilibrium [Finding]
   742   C0394006:Disequilibrium [Disease or Syndrome]
   742   C0456603:Ratio [Quantitative Concept]
   742   C0549193:Parameter [Spatial Concept]
   742   C1547037:Ratio [Intellectual Product]
   742   C1704769:Parameter [Conceptual Entity]
   742   C1704788:Defined [Conceptual Entity]
   742   C2350001:Parameter [Quantitative Concept]
   742   C3539106:Defined [Intellectual Product]

Phrase: "to the possible maximum linkage disequilibrium parameter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0549193:Parameter [Spatial Concept]
   804   C1704769:Parameter [Conceptual Entity]
   804   C2350001:Parameter [Quantitative Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.105: To examine deviations from linkage equilibrium between the two SNPs, a 2 test was performed as described by Imanishi et al. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "deviations from linkage equilibrium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0012727:Deviation [Spatial Concept]
   737   C0205419:Deviation [Qualitative Concept]
   737   C1705236:Deviation [Finding]

Phrase: "between the two SNPs,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "a 2 test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described by Imanishi et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.106: (15). 

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.107: In the case of haplotypes consisting of three SNPs, linkage disequilibrium was defined as the difference between the estimated haplotype frequency and the product of each allele frequency. 

Phrase: "In the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "consisting of three SNPs,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   753   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0032529:polymorphisms [Genetic Function]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C0205449:Three [Quantitative Concept]
   719   C0332529:CONSIST [Qualitative Concept]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "was"

Phrase: "defined as the difference"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1704788:Defined [Conceptual Entity]
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]
   770   C3539106:Defined [Intellectual Product]

Phrase: "between the estimated haplotype frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   755 E C0332183:Frequent [Temporal Concept]

Phrase: "and"

Phrase: "the product of each allele frequency."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1514468:product [Entity]
   753   C1704444:Product [Quantitative Concept]
Processing 00000000.tx.108: For the test of linkage disequilibrium between three SNPs, a likelihood ratio test in the EH program (13) was performed.  

Phrase: "For the test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "of linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "between three SNPs,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "a likelihood ratio test in the EH program"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0150102:LIKELIHOOD RATIO [Quantitative Concept]
   744   C0022885:Test [Laboratory Procedure]
   744   C0033204:Likelihood [Quantitative Concept]
   744   C0039593:Test [Functional Concept]
   744   C0392366:test [Intellectual Product]
   744   C0456603:Ratio [Quantitative Concept]
   744   C1547037:Ratio [Intellectual Product]

Phrase: "(13"

Phrase: ")"

Phrase: "was"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.109: ACKNOWLEDGMENTS  This work was supported by Grant-in-Aid 12204007 for Scientific Research on Priority Areas (C) "Medical Genome Science" from the Ministry of Education, Science, Sports and Culture; 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by Grant-in-Aid 12204007"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0018173:Grant [Quantitative Concept]
   753   C0018896:Aid [Social Behavior]
   753   C0449435:Aid [Manufactured Object]
   753   C1521721:Supported [Conceptual Entity]
   753   C1548284:Grant [Idea or Concept]
   753   C3540469:AID [Gene or Genome]
   719 E C0183683:Support [Medical Device]

Phrase: "for Scientific Research"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0683933:scientific research [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0036397:Scientific [Occupation or Discipline]
   861   C0242481:Research [Research Activity]

Phrase: "on Priority Areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]

Phrase: "(C) ""Medical Genome Science"""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0025118:Medical Science [Biomedical Occupation or Discipline]
   812   C0036397:Science [Occupation or Discipline]

Phrase: "from the Ministry"

Phrase: "of Education,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0013621:Education [Educational Activity]
  1000   C0013622:education [Classification]
  1000   C0013658:Education, NOS [Finding]
  1000   C0039401:Education [Educational Activity]
   928 E C1555905:Educational [Intellectual Product]

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "Sports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038039:Sports [Daily or Recreational Activity]
  1000   C1552306:Sports [Professional or Occupational Group]

Phrase: "and"

Phrase: "Culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.110: Grant-in-Aid 11671122 and 11671124 for Scientific Research (C) from the Japan Society for the Promotion of Science; 

Phrase: "Grant-in-Aid 11671122"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0018173:Grant [Quantitative Concept]
   812   C0018896:Aid [Social Behavior]
   812   C0449435:Aid [Manufactured Object]
   812   C1548284:Grant [Idea or Concept]
   812   C3540469:AID [Gene or Genome]

Phrase: "and"

Phrase: "11671124 for Scientific Research"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0683933:scientific research [Research Activity]
   770   C0035168:research [Research Activity]
   770   C0036397:Scientific [Occupation or Discipline]
   770   C0242481:Research [Research Activity]

Phrase: "(C) from the Japan Society"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1553033:[c] [Quantitative Concept]

Phrase: "for the Promotion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promotion [Activity]

Phrase: "of Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: ";"
Processing 00000000.tx.111: and the Charitable Trust Clinical Pathology Research Foundation in Japan. 

Phrase: "and"

Phrase: "the Charitable Trust Clinical Pathology Research Foundation in Japan."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0016617:Foundation [Organization]
   723   C2986512:Research Base [Organization]
Processing 00000000.tx.112: We thank K. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.113: Nakamaru, F. 

Phrase: "Nakamaru,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.114: Tanabe, and M. 

Phrase: "Tanabe,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.115: Murase for technical assistance and suggestions.  

Phrase: "Murase for technical assistance"

Phrase: "and"

Phrase: "suggestions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0038659:Suggestions [Idea or Concept]
   966 E C1705535:suggestion [Idea or Concept]
Processing 00000000.tx.116: FOOTNOTES  Address correspondence and reprint requests to Dr. 

Phrase: "FOOTNOTES  Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Dr."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0031831:DR [Professional or Occupational Group]
   790   C0686900:request [Functional Concept]
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.117: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.118: Osawa, Department of Laboratory Medicine Ehime University School of Medicine, Shigenobu, Ehime 791-0295, Japan. 

Phrase: "Osawa,"

Phrase: "Department of Laboratory Medicine Ehime University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1704729:Department [Organization]

Phrase: "Shigenobu,"

Phrase: "Ehime 791-0295,"

Phrase: "Japan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]
Processing 00000000.tx.119: E-mail: harosawa{at}m.ehime-u.ac.jp . Received for publication 29 August 2001 and accepted in revised form 19 November 2001. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "harosawa{at}"

Phrase: "m."

Phrase: "ehime-u.ac.jp ."

Phrase: "Received for publication 29 August 2001"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0034036:Publication [Intellectual Product,Manufactured Object]
   753   C0034037:Publication [Occupational Activity]
   753   C1514756:Received [Qualitative Concept]
   753   C1704324:Publication [Intellectual Product]

Phrase: "and"

Phrase: "accepted in revised form 19 November 2001."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1272684:Accepted [Qualitative Concept]
   748   C1522492:Form [Functional Concept]
   748   C1527075:Revised [Therapeutic or Preventive Procedure]
   748   C1548435:Accepted [Idea or Concept]
   714 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.120: PPAR-, peroxisome proliferatoractivated receptor-; 

Phrase: "PPAR-"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0752063:Peroxysome [Cell Component]
   827   C2984308:Peroxisome [Functional Concept]
   755 E C3546463:peroxisomal [Cell Component]

Phrase: ","

Phrase: "peroxisome proliferatoractivated receptor-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.121: RELM, resistin-like molecule; 

Phrase: "RELM,"

Phrase: "resistin-like molecule"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0567416:Molecule [Substance]
   827   C0963992:resistin [Amino Acid, Peptide, or Protein,Hormone]
   827   C1426906:RESISTIN [Gene or Genome]
   755 E C1521991:Molecular [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.122: SNP, single nucleotide polymorphism.  

Phrase: "SNP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0752046:SNP [Nucleotide Sequence]
  1000   C1527094:SNP [Conceptual Entity]

Phrase: "single nucleotide polymorphism."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:Polymorphism [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   827   C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.123: REFERENCES TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS REFERENCES  DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: a balanced overview. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "DeFronzo RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Bonadonna RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Ferrannini E"

Phrase: ":"

Phrase: "Pathogenesis of NIDDM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0543483:pathogenesis [Functional Concept]
   790   C0699748:Pathogenesis [Pathologic Function]

Phrase: ":"

Phrase: "a balanced overview."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0814812:overview [Intellectual Product]
Processing 00000000.tx.124: Diabetes Care 15:318368, 1992[Abstract] Groop LC: The molecular genetics of non-insulin-dependent diabetes mellitus (Editorial). 

Phrase: "Diabetes Care 15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C1947933:Care [Activity]

Phrase: ":"

Phrase: "318368,"

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Groop LC"

Phrase: ":"

Phrase: "The molecular genetics of non-insulin-dependent diabetes mellitus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   784   C0596425:diabetes mellitus genetics [Occupation or Discipline]
   764   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   742   C0017398:Genetics [Biomedical Occupation or Discipline]
   742   C0017399:genetics [Biologic Function]
   742   C1521991:Molecular [Qualitative Concept]

Phrase: "(Editorial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282412:Editorial [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.125: J Intern Med 241:95101, 1997[Medline] Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES: The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. 

Phrase: "J Intern Med 241"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1144859:INTERN [Professional or Occupational Group]

Phrase: ":"

Phrase: "95101,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Altshuler D,"

Phrase: "Hirschhorn JN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428813:JN [Gene or Genome]

Phrase: "Klannemark M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lindgren CM,"

Phrase: "Vohl MC,"

Phrase: "Nemesh J,"

Phrase: "Lane CR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: "Schaffner SF,"

Phrase: "Bolk S,"

Phrase: "Brewer C,"

Phrase: "Tuomi T,"

Phrase: "Gaudet D,"

Phrase: "Hudson TJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: "Daly M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Groop L,"

Phrase: "Lander ES"

Phrase: ":"

Phrase: "The common PPARgamma Pro12Ala polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032529:Polymorphism [Genetic Function]
   812   C1882417:Polymorphism [Qualitative Concept]

Phrase: "is"

Phrase: "associated with decreased risk of type 2 diabetes."
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   800   C0011860:Type 2 Diabetes [Disease or Syndrome]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0441730:Type 2 [Classification]
   767   C1171304:diabetes risk [Quantitative Concept]
   767   C1320657:Diabetes type [Finding]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0035647:Risk [Qualitative Concept]
   744   C0205216:Decreased [Quantitative Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C0392756:Decreased [Qualitative Concept]
   744   C0442797:decreased [Qualitative Concept]
   744   C1547052:*Type [Quantitative Concept]
   711 E C0547047:Decrease [Quantitative Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.126: Nat Genet 26:7680, 2000[Medline] Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PE, del Bosque-Plata L, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, Bell GI: Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. 

Phrase: "Nat Genet 26"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "7680,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Horikawa Y,"

Phrase: "Oda N,"

Phrase: "Cox NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Li X,"

Phrase: "Orho-Melander M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Hara M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hinokio Y,"

Phrase: "Lindner TH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039725:TH [Geographic Area]
   861   C0039738:Th [Element, Ion, or Isotope]
   861   C1420718:TH [Gene or Genome]

Phrase: "Mashima H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Schwarz PE,"

Phrase: "del Bosque-Plata L,"

Phrase: "Oda Y,"

Phrase: "Yoshiuchi I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Colilla S,"

Phrase: "Polonsky KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Wei S,"

Phrase: "Concannon P,"

Phrase: "Iwasaki N,"

Phrase: "Schulze J,"

Phrase: "Baier LJ,"

Phrase: "Bogardus C,"

Phrase: "Groop L,"

Phrase: "Boerwinkle E,"

Phrase: "Hanis CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Bell GI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: ":"

Phrase: "Genetic variation in the gene encoding calpain-10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0042333:Genetic Variation [Natural Phenomenon or Process]
   744   C0205419:Variation [Qualitative Concept]

Phrase: "is"

Phrase: "associated with type 2 diabetes mellitus."
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   882   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
   882   C2984301:Type II diabetes mellitus [Functional Concept]
   790   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0441730:Type 2 [Classification]
   783   C1320657:Diabetes type [Finding]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.127: Nat Genet 26:163175, 2000[Medline] Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. 

Phrase: "Nat Genet 26"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "163175,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Steppan CM,"

Phrase: "Bailey ST,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "Bhat S,"

Phrase: "Brown EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "Banerjee RR,"

Phrase: "Wright CM,"

Phrase: "Patel HR,"

Phrase: "Ahima RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539879:RS [Idea or Concept]

Phrase: "Lazar MA"

Phrase: ":"

Phrase: "The hormone resistin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0963992:resistin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1426906:RESISTIN [Gene or Genome]

Phrase: "links"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "obesity to diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C2945676:diabetes obesity [Finding]
   790   C0028754:Obesity [Disease or Syndrome]
   790   C1963185:Obesity [Finding]
Processing 00000000.tx.128: Nature 409:307312, 2001[Medline] DeFronzo RA, Ferrannini E, Simonson DC: Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. 

Phrase: "Nature 409"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "307312,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] DeFronzo RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Ferrannini E,"

Phrase: "Simonson DC"

Phrase: ":"

Phrase: "Fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "hyperglycemia in non-insulin-dependent diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0020456:Hyperglycaemia [Disease or Syndrome]
   731   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
   731   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]

Phrase: ":"

Phrase: "contributions of excessive hepatic glucose production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1880177:Contribution [Activity]

Phrase: "and"

Phrase: "impaired tissue glucose uptake."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1159527:glucose uptake [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.129: Metabolism 38:387395, 1989[Medline] Kosaka K, Kuzuya T, Hagura R: Insulin secretory response in Japanese type 2 (non-insulin-dependent) diabetic patients. 

Phrase: "Metabolism 38"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: ":"

Phrase: "387395,"

Phrase: "1989"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kosaka K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kuzuya T,"

Phrase: "Hagura R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Insulin secretory response in Japanese type 2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "(non-insulin-dependent) diabetic patients."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   881   C1829939:{Non-patient} [Clinical Attribute]
   853   C0581116:dependent patients [Functional Concept]
   804   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.130: Diabetes Res Clin Pract 24 (Suppl.):S101S110, 1994[Medline] Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY, Enders GH, Silberg DG, Wen X, Wu GD, Lazar MA: A family of tissue-specific resistin-like molecules. 

Phrase: "Diabetes Res Clin Pract 24"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0011849:Diabetes [Disease or Syndrome]
   804   C1315013:CLIN [Intellectual Product]
   804   C2347379:RES [Finding]

Phrase: "(Suppl.):S101S110,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Steppan CM,"

Phrase: "Brown EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "Wright CM,"

Phrase: "Bhat S,"

Phrase: "Banerjee RR,"

Phrase: "Dai CY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010622:CY [Geographic Area]
   861   C0332298:CY [Functional Concept]

Phrase: "Enders GH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033993:GH [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539616:GH [Gene or Genome]

Phrase: "Silberg DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Wen X,"

Phrase: "Wu GD,"

Phrase: "Lazar MA"

Phrase: ":"

Phrase: "A family of tissue-specific resistin-like molecules."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0015576:Family [Family Group]
   744   C1704727:Family [Conceptual Entity]
Processing 00000000.tx.131: Proc Natl Acad Sci U S A 98:502506, 2001[Abstract/Free FullText] Way JM, Gorgun CZ, Tong Q, Uysal KT, Brown KK, Harrington WW, Oliver WR Jr, Willson TM, Kliewer SA, Hotamisligil GS: Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists. 

Phrase: "Proc Natl Acad Sci U S A 98"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "502506,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Way JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Gorgun CZ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206578:CZ [Geographic Area]

Phrase: "Tong Q,"

Phrase: "Uysal KT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1690540:KT [Qualitative Concept]
   861   C3484384:Kt [Quantitative Concept]

Phrase: "Brown KK,"

Phrase: "Harrington WW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1861696:WW [Disease or Syndrome]

Phrase: "Oliver WR Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "Willson TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Kliewer SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Hotamisligil GS"

Phrase: ":"

Phrase: "Adipose tissue resistin expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "severely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205082:Severely [Qualitative Concept]

Phrase: "suppressed in obesity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028754:Obesity [Disease or Syndrome]
   790   C1260953:Suppressed [Functional Concept]
   790   C1963185:Obesity [Finding]

Phrase: "and"

Phrase: "stimulated by peroxisome proliferator-activated receptor gamma agonists."
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   909   C2916798:Peroxisome Proliferator-activated Receptor gamma Agonists [Molecular Function]
   869   C0166417:Peroxisome Proliferator-Activated Receptor gamma [Amino Acid, Peptide, or Protein,Receptor]
   869   C1335238:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA [Gene or Genome]
   840   C2917405:Peroxisome Proliferator Receptor gamma Agonist [Pharmacologic Substance]
   833   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   833   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   770   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   744   C0017011:Gamma [Natural Phenomenon or Process]
   744   C0243192:agonists [Pharmacologic Substance]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C0752063:Peroxysome [Cell Component]
   744   C1552644:Gamma [Intellectual Product]
   744   C1879547:Activated [Activity]
   744   C1948023:Stimulated [Natural Phenomenon or Process]
   744   C2349976:Gamma [Quantitative Concept]
   744   C2984308:Peroxisome [Functional Concept]
   744   C2987634:agonists [Pharmacologic Substance]
   711 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.132: J Biol Chem 276:2565125653, 2001[Abstract/Free FullText] The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. 

Phrase: "J Biol Chem 276"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2565125653,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "The Expert Committee on the Diagnosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2699414:Committee [Group]

Phrase: "and"

Phrase: "Classification of Diabetes Mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0008902:Classification [Classification]
   770   C0008903:classification [Functional Concept]
   770   C0678229:classification [Occupational Activity]

Phrase: ":"

Phrase: "Report of the Expert Committee"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0684224:Report [Intellectual Product]
   760   C0700287:Report [Health Care Activity]
   760   C3273238:Report [Intellectual Product]

Phrase: "on the Diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "and"

Phrase: "Classification of Diabetes Mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0008902:Classification [Classification]
   770   C0008903:classification [Functional Concept]
   770   C0678229:classification [Occupational Activity]
Processing 00000000.tx.133: Diabetes Care 23 (Suppl. 1):S4S19, 2000[Medline] Osawa H, Onuma H, Murakami A, Ochi M, Nishimiya T, Kato K, Shimizu I, Fujii Y, Ohashi J, Makino H: Systematic search for single nucleotide polymorphisms in the insulin gene: evidence for a high frequency of -23T>A in Japanese subjects. 

Phrase: "Diabetes Care 23"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0450348:23 [Quantitative Concept]
   827   C1947933:Care [Activity]

Phrase: "(Suppl. 1"

Phrase: ")"

Phrase: ":"

Phrase: "S4S19,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Osawa H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Onuma H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Murakami A,"

Phrase: "Ochi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Nishimiya T,"

Phrase: "Kato K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Shimizu I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Fujii Y,"

Phrase: "Ohashi J,"

Phrase: "Makino H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Systematic search for single nucleotide polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1552603:search [Intellectual Product]
   753   C1706202:Search [Activity]

Phrase: "in the insulin gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1337112:Insulin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: ":"

Phrase: "evidence for a high frequency of -23T"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: ">A in Japanese subjects."
Processing 00000000.tx.134: Biochem Biophys Res Commun 286:451455, 2001[Medline] Osawa H, Nishimiya T, Ochi M, Niiya T, Onuma H, Kitamuro F, Kaino Y, Kida K, Makino H: Identification of novel C253Y missense and Y864X nonsense mutations in the insulin receptor gene in type A insulin-resistant patients. 

Phrase: "Biochem Biophys Res Commun 286"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "451455,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Osawa H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Nishimiya T,"

Phrase: "Ochi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Niiya T,"

Phrase: "Onuma H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kitamuro F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Kaino Y,"

Phrase: "Kida K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Makino H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Identification of novel C253Y missense"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "Y864X nonsense mutations in the insulin receptor gene"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0544885:Nonsense Mutations [Cell or Molecular Dysfunction]
   767   C0596611:gene mutations [Genetic Function]
   744   C0026882:Mutations [Genetic Function]
   744   C0746939:nonsense [Idea or Concept]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in type A insulin-resistant patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.135: Clin Genet 59:194197, 2001[Medline] Terwillinger J, Otto J: Handbook of Human Linkage Analysis. 

Phrase: "Clin Genet 59"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0325074:Genet [Mammal]
   827   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "194197,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Terwillinger J,"

Phrase: "Otto J"

Phrase: ":"

Phrase: "Handbook of Human Linkage Analysis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596654:handbook [Intellectual Product]
Processing 00000000.tx.136: Baltimore, MD, Johns Hopkins University Press, 1994 Lewontin R: The interaction of selection and linkage. 

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "MD,"

Phrase: "Johns Hopkins University Press,"

Phrase: "1994 Lewontin R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "The interaction of selection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "linkage."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023745:linkage [Molecular Function]
Processing 00000000.tx.137: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.138: General considerations, heterotic models. 

Phrase: "General considerations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0518609:considerations [Finding]

Phrase: "heterotic models."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]
Processing 00000000.tx.139: Genetics 49:4967, 1964[Free FullText] Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T: Estimation of allelle and haplotype frequencies for HLA and complement loci. 

Phrase: "Genetics 49"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]

Phrase: ":"

Phrase: "4967,"

Phrase: "1964"

Phrase: "[Free FullText"

Phrase: "] Imanishi T,"

Phrase: "Akaza T,"

Phrase: "Kimura A,"

Phrase: "Tokunaga K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Gojobori T"

Phrase: ":"

Phrase: "Estimation of allelle"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0680844:estimation [Mental Process]
   790   C0681916:Estimation [Quantitative Concept]
   790   C0750572:Estimation [Quantitative Concept]

Phrase: "and"

Phrase: "haplotype frequencies for HLA"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   770   C0439603:Frequencies [Temporal Concept]
   737 E C0376249:frequency [Quantitative Concept]
   737 E C0871396:Frequency [Quantitative Concept]
   737 E C1561548:Frequency [Qualitative Concept]
   737 E C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "complement loci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.140: In HLA 1991. 

Phrase: "In HLA 1991."
Processing 00000000.tx.141: Proceedings of the Eleventh International Histocompatibility Workshop and Conference. 

Phrase: "Proceedings of the Eleventh International Histocompatibility Workshop"

Phrase: "and"

Phrase: "Conference."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086047:Conference [Human-caused Phenomenon or Process]
Processing 00000000.tx.142: Vol. 

Phrase: "Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.143: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.144: Tsuji K, Aizawa M, Sasazuki T, Eds. 

Phrase: "Tsuji K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Aizawa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sasazuki T,"

Phrase: "Eds."
Processing 00000000.tx.145: Oxford, U.K., Oxford University Press, 1992, p.7679

Phrase: "Oxford,"

Phrase: "U.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Oxford University Press,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "1992,"

Phrase: "p.7679"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

